Motif 1111 (n=80)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A5A3E0 | POTEF | Y940 | ochoa | POTE ankyrin domain family member F (ANKRD26-like family C member 1B) (Chimeric POTE-actin protein) | None |
A6NKT7 | RGPD3 | S1482 | ochoa | RanBP2-like and GRIP domain-containing protein 3 | None |
O00267 | SUPT5H | T1036 | ochoa | Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein) | Component of the DRB sensitivity-inducing factor complex (DSIF complex), which regulates mRNA processing and transcription elongation by RNA polymerase II (PubMed:10075709, PubMed:10199401, PubMed:10421630, PubMed:10757782, PubMed:10912001, PubMed:11112772, PubMed:11553615, PubMed:12653964, PubMed:12718890, PubMed:15136722, PubMed:15380072, PubMed:9450929, PubMed:9857195). DSIF positively regulates mRNA capping by stimulating the mRNA guanylyltransferase activity of RNGTT/CAP1A (PubMed:10075709, PubMed:10421630, PubMed:10757782, PubMed:10912001, PubMed:11112772, PubMed:11553615, PubMed:12653964, PubMed:12718890, PubMed:15136722, PubMed:15380072, PubMed:9450929, PubMed:9857195). DSIF also acts cooperatively with the negative elongation factor complex (NELF complex) to enhance transcriptional pausing at sites proximal to the promoter (PubMed:10075709, PubMed:10199401, PubMed:10757782, PubMed:10912001, PubMed:11112772, PubMed:11553615, PubMed:12653964, PubMed:12718890, PubMed:15136722, PubMed:15380072, PubMed:9450929, PubMed:9857195). Transcriptional pausing may facilitate the assembly of an elongation competent RNA polymerase II complex (PubMed:10075709, PubMed:10199401, PubMed:10421630, PubMed:10757782, PubMed:10912001, PubMed:11112772, PubMed:11553615, PubMed:12653964, PubMed:12718890, PubMed:15136722, PubMed:15380072, PubMed:9450929, PubMed:9857195). DSIF and NELF promote pausing by inhibition of the transcription elongation factor TFIIS/S-II (PubMed:16214896). TFIIS/S-II binds to RNA polymerase II at transcription pause sites and stimulates the weak intrinsic nuclease activity of the enzyme (PubMed:16214896). Cleavage of blocked transcripts by RNA polymerase II promotes the resumption of transcription from the new 3' terminus and may allow repeated attempts at transcription through natural pause sites (PubMed:16214896). Following phosphorylation by CDK9, DSIF can also positively regulate transcriptional elongation (PubMed:16427012). Required for the efficient activation of transcriptional elongation by the HIV-1 nuclear transcriptional activator, Tat (PubMed:10393184, PubMed:10454543, PubMed:11809800, PubMed:9514752). DSIF acts to suppress transcriptional pausing in transcripts derived from the HIV-1 LTR and blocks premature release of HIV-1 transcripts at terminator sequences (PubMed:11112772, PubMed:14701750). {ECO:0000269|PubMed:10075709, ECO:0000269|PubMed:10199401, ECO:0000269|PubMed:10393184, ECO:0000269|PubMed:10421630, ECO:0000269|PubMed:10454543, ECO:0000269|PubMed:10757782, ECO:0000269|PubMed:10912001, ECO:0000269|PubMed:11112772, ECO:0000269|PubMed:11553615, ECO:0000269|PubMed:11809800, ECO:0000269|PubMed:12653964, ECO:0000269|PubMed:12718890, ECO:0000269|PubMed:14701750, ECO:0000269|PubMed:15136722, ECO:0000269|PubMed:15380072, ECO:0000269|PubMed:16214896, ECO:0000269|PubMed:16427012, ECO:0000269|PubMed:9450929, ECO:0000269|PubMed:9514752, ECO:0000269|PubMed:9857195}. |
O00303 | EIF3F | T255 | ochoa | Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47) | Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03005, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.; FUNCTION: Deubiquitinates activated NOTCH1, promoting its nuclear import, thereby acting as a positive regulator of Notch signaling. {ECO:0000269|PubMed:21124883}. |
O14715 | RGPD8 | S1481 | ochoa | RANBP2-like and GRIP domain-containing protein 8 (Ran-binding protein 2-like 3) (RanBP2-like 3) (RanBP2L3) | None |
O15198 | SMAD9 | T324 | ochoa | Mothers against decapentaplegic homolog 9 (MAD homolog 9) (Mothers against DPP homolog 9) (Madh6) (SMAD family member 9) (SMAD 9) (Smad9) | Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD9 is a receptor-regulated SMAD (R-SMAD). |
O15234 | CASC3 | T155 | ochoa | Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein) (MLN 51) (Protein barentsz) (Btz) | Required for pre-mRNA splicing as component of the spliceosome (PubMed:28502770, PubMed:29301961). Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). Stimulates the ATPase and RNA-helicase activities of EIF4A3. Plays a role in the stress response by participating in cytoplasmic stress granules assembly and by favoring cell recovery following stress. Component of the dendritic ribonucleoprotein particles (RNPs) in hippocampal neurons. May play a role in mRNA transport. Binds spliced mRNA in sequence-independent manner, 20-24 nucleotides upstream of mRNA exon-exon junctions. Binds poly(G) and poly(U) RNA homomer. {ECO:0000269|PubMed:17375189, ECO:0000269|PubMed:17652158, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961}. |
O75469 | NR1I2 | T133 | psp | Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR) | Nuclear receptor that binds and is activated by variety of endogenous and xenobiotic compounds. Transcription factor that activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs and endogenous compounds. Activated by the antibiotic rifampicin and various plant metabolites, such as hyperforin, guggulipid, colupulone, and isoflavones. Response to specific ligands is species-specific. Activated by naturally occurring steroids, such as pregnenolone and progesterone. Binds to a response element in the promoters of the CYP3A4 and ABCB1/MDR1 genes. {ECO:0000269|PubMed:11297522, ECO:0000269|PubMed:11668216, ECO:0000269|PubMed:12578355, ECO:0000269|PubMed:18768384, ECO:0000269|PubMed:19297428, ECO:0000269|PubMed:9727070}. |
O75469 | NR1I2 | T248 | psp | Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR) | Nuclear receptor that binds and is activated by variety of endogenous and xenobiotic compounds. Transcription factor that activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs and endogenous compounds. Activated by the antibiotic rifampicin and various plant metabolites, such as hyperforin, guggulipid, colupulone, and isoflavones. Response to specific ligands is species-specific. Activated by naturally occurring steroids, such as pregnenolone and progesterone. Binds to a response element in the promoters of the CYP3A4 and ABCB1/MDR1 genes. {ECO:0000269|PubMed:11297522, ECO:0000269|PubMed:11668216, ECO:0000269|PubMed:12578355, ECO:0000269|PubMed:18768384, ECO:0000269|PubMed:19297428, ECO:0000269|PubMed:9727070}. |
P00367 | GLUD1 | T228 | ochoa | Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3) | Mitochondrial glutamate dehydrogenase that catalyzes the conversion of L-glutamate into alpha-ketoglutarate. Plays a key role in glutamine anaplerosis by producing alpha-ketoglutarate, an important intermediate in the tricarboxylic acid cycle (PubMed:11032875, PubMed:11254391, PubMed:16023112, PubMed:16959573). Plays a role in insulin homeostasis (PubMed:11297618, PubMed:9571255). May be involved in learning and memory reactions by increasing the turnover of the excitatory neurotransmitter glutamate (By similarity). {ECO:0000250|UniProtKB:P10860, ECO:0000269|PubMed:11032875, ECO:0000269|PubMed:11254391, ECO:0000269|PubMed:11297618, ECO:0000269|PubMed:16023112, ECO:0000269|PubMed:16959573, ECO:0000269|PubMed:9571255}. |
P0DJD0 | RGPD1 | S1466 | ochoa | RANBP2-like and GRIP domain-containing protein 1 (Ran-binding protein 2-like 6) (RanBP2-like 6) (RanBP2L6) | None |
P0DJD1 | RGPD2 | S1474 | ochoa | RANBP2-like and GRIP domain-containing protein 2 (Ran-binding protein 2-like 2) (RanBP2-like 2) (RanBP2L2) | None |
P0DPH7 | TUBA3C | T223 | ochoa | Tubulin alpha-3C chain (EC 3.6.5.-) (Alpha-tubulin 2) (Alpha-tubulin 3C) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-3C chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P0DPH8 | TUBA3D | T223 | ochoa | Tubulin alpha-3D chain (EC 3.6.5.-) (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P11166 | SLC2A1 | T234 | ochoa | Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter) | Facilitative glucose transporter, which is responsible for constitutive or basal glucose uptake (PubMed:10227690, PubMed:10954735, PubMed:18245775, PubMed:19449892, PubMed:25982116, PubMed:27078104, PubMed:32860739). Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses (PubMed:18245775, PubMed:19449892). Most important energy carrier of the brain: present at the blood-brain barrier and assures the energy-independent, facilitative transport of glucose into the brain (PubMed:10227690). In association with BSG and NXNL1, promotes retinal cone survival by increasing glucose uptake into photoreceptors (By similarity). Required for mesendoderm differentiation (By similarity). {ECO:0000250|UniProtKB:P17809, ECO:0000250|UniProtKB:P46896, ECO:0000269|PubMed:10227690, ECO:0000269|PubMed:10954735, ECO:0000269|PubMed:18245775, ECO:0000269|PubMed:19449892, ECO:0000269|PubMed:25982116, ECO:0000269|PubMed:27078104, ECO:0000269|PubMed:32860739}. |
P11169 | SLC2A3 | T232 | ochoa | Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3) | Facilitative glucose transporter (PubMed:26176916, PubMed:32860739, PubMed:9477959). Can also mediate the uptake of various other monosaccharides across the cell membrane (PubMed:26176916, PubMed:9477959). Mediates the uptake of glucose, 2-deoxyglucose, galactose, mannose, xylose and fucose, and probably also dehydroascorbate (PubMed:26176916, PubMed:9477959). Does not mediate fructose transport (PubMed:26176916, PubMed:9477959). Required for mesendoderm differentiation (By similarity). {ECO:0000250|UniProtKB:P32037, ECO:0000269|PubMed:26176916, ECO:0000269|PubMed:32860739, ECO:0000269|PubMed:8457197, ECO:0000269|PubMed:9477959}. |
P22090 | RPS4Y1 | T33 | ochoa | Small ribosomal subunit protein eS4, Y isoform 1 (40S ribosomal protein S4) | None |
P30305 | CDC25B | T404 | psp | M-phase inducer phosphatase 2 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25B) | Tyrosine protein phosphatase which functions as a dosage-dependent inducer of mitotic progression (PubMed:1836978, PubMed:20360007). Directly dephosphorylates CDK1 and stimulates its kinase activity (PubMed:20360007). Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner (PubMed:17332740). The three isoforms seem to have a different level of activity (PubMed:1836978). {ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:1836978, ECO:0000269|PubMed:20360007}. |
P33981 | TTK | T594 | psp | Dual specificity protein kinase TTK (EC 2.7.12.1) (Phosphotyrosine picked threonine-protein kinase) (PYT) | Involved in mitotic spindle assembly checkpoint signaling, a process that delays anaphase until chromosomes are bioriented on the spindle, and in the repair of incorrect mitotic kinetochore-spindle microtubule attachments (PubMed:18243099, PubMed:28441529, PubMed:29162720). Phosphorylates MAD1L1 to promote the mitotic spindle assembly checkpoint (PubMed:18243099, PubMed:29162720). Phosphorylates CDCA8/Borealin leading to enhanced AURKB activity at the kinetochore (PubMed:18243099). Phosphorylates SKA3 at 'Ser-34' leading to dissociation of the SKA complex from microtubules and destabilization of microtubule-kinetochore attachments (PubMed:28441529). Phosphorylates KNL1, KNTC1 and autophosphorylates (PubMed:28441529). Phosphorylates MCRS1 which enhances recruitment of KIF2A to the minus end of spindle microtubules and promotes chromosome alignment (PubMed:30785839). {ECO:0000269|PubMed:18243099, ECO:0000269|PubMed:28441529, ECO:0000269|PubMed:29162720, ECO:0000269|PubMed:30785839}. |
P35609 | ACTN2 | T178 | ochoa | Alpha-actinin-2 (Alpha-actinin skeletal muscle isoform 2) (F-actin cross-linking protein) | F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein. |
P35609 | ACTN2 | T308 | ochoa | Alpha-actinin-2 (Alpha-actinin skeletal muscle isoform 2) (F-actin cross-linking protein) | F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein. |
P49792 | RANBP2 | S2457 | ochoa | E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) | E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:15931224, PubMed:22194619). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Inhibits EIF4E-dependent mRNA export (PubMed:22902403). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:22902403, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}. |
P51153 | RAB13 | T49 | ochoa | Ras-related protein Rab-13 (EC 3.6.5.2) (Cell growth-inhibiting gene 4 protein) | The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. RAB13 is involved in endocytic recycling and regulates the transport to the plasma membrane of transmembrane proteins like the tight junction protein OCLN/occludin. Thereby, it regulates the assembly and the activity of tight junctions. Moreover, it may also regulate tight junction assembly by activating the PKA signaling pathway and by reorganizing the actin cytoskeleton through the activation of the downstream effectors PRKACA and MICALL2 respectively. Through its role in tight junction assembly, may play a role in the establishment of Sertoli cell barrier. Plays also a role in angiogenesis through regulation of endothelial cells chemotaxis. Also involved in neurite outgrowth. Has also been proposed to play a role in post-Golgi membrane trafficking from the TGN to the recycling endosome. Finally, it has been involved in insulin-induced transport to the plasma membrane of the glucose transporter GLUT4 and therefore may play a role in glucose homeostasis. {ECO:0000269|PubMed:12058051, ECO:0000269|PubMed:15096524, ECO:0000269|PubMed:15528189, ECO:0000269|PubMed:16525024, ECO:0000269|PubMed:18779367, ECO:0000269|PubMed:20008558, ECO:0000269|PubMed:35343654}. |
P55011 | SLC12A2 | T266 | ochoa | Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (hNKCC1) | Cation-chloride cotransporter which mediates the electroneutral transport of chloride, potassium and/or sodium ions across the membrane (PubMed:16669787, PubMed:32081947, PubMed:32294086, PubMed:33597714, PubMed:35585053, PubMed:36239040, PubMed:36306358, PubMed:7629105). Plays a vital role in the regulation of ionic balance and cell volume (PubMed:16669787, PubMed:32081947, PubMed:32294086, PubMed:7629105). {ECO:0000269|PubMed:16669787, ECO:0000269|PubMed:32081947, ECO:0000269|PubMed:32294086, ECO:0000269|PubMed:33597714, ECO:0000269|PubMed:35585053, ECO:0000269|PubMed:36239040, ECO:0000269|PubMed:36306358, ECO:0000269|PubMed:7629105}. |
P60709 | ACTB | Y240 | ochoa | Actin, cytoplasmic 1 (EC 3.6.4.-) (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed] | Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (PubMed:25255767, PubMed:29581253). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (PubMed:29581253). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damaged DNA (PubMed:29925947). Plays a role in the assembly of the gamma-tubulin ring complex (gTuRC), which regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments (PubMed:39321809, PubMed:38609661). Part of the ACTR1A/ACTB filament around which the dynactin complex is built (By similarity). The dynactin multiprotein complex activates the molecular motor dynein for ultra-processive transport along microtubules (By similarity). {ECO:0000250|UniProtKB:Q6QAQ1, ECO:0000269|PubMed:25255767, ECO:0000269|PubMed:29581253, ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:38609661, ECO:0000269|PubMed:39321809}. |
P62701 | RPS4X | T33 | ochoa | Small ribosomal subunit protein eS4, X isoform (40S ribosomal protein S4) (SCR10) (Single copy abundant mRNA protein) | Component of the small ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). {ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:34516797}. |
P62736 | ACTA2 | Y242 | ochoa | Actin, aortic smooth muscle (EC 3.6.4.-) (Alpha-actin-2) (Cell growth-inhibiting gene 46 protein) [Cleaved into: Actin, aortic smooth muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P63241 | EIF5A | T76 | ochoa | Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (Rev-binding factor) (eIF-4D) | Translation factor that promotes translation elongation and termination, particularly upon ribosome stalling at specific amino acid sequence contexts (PubMed:33547280). Binds between the exit (E) and peptidyl (P) site of the ribosome and promotes rescue of stalled ribosome: specifically required for efficient translation of polyproline-containing peptides as well as other motifs that stall the ribosome (By similarity). Acts as a ribosome quality control (RQC) cofactor by joining the RQC complex to facilitate peptidyl transfer during CAT tailing step (By similarity). Also involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity (PubMed:16987817). With syntenin SDCBP, functions as a regulator of p53/TP53 and p53/TP53-dependent apoptosis (PubMed:15371445). Also regulates TNF-alpha-mediated apoptosis (PubMed:15452064, PubMed:17187778). Mediates effects of polyamines on neuronal process extension and survival (PubMed:17360499). Is required for autophagy by assisting the ribosome in translating the ATG3 protein at a specific amino acid sequence, the 'ASP-ASP-Gly' motif, leading to the increase of the efficiency of ATG3 translation and facilitation of LC3B lipidation and autophagosome formation (PubMed:29712776). {ECO:0000250|UniProtKB:P23301, ECO:0000269|PubMed:15371445, ECO:0000269|PubMed:15452064, ECO:0000269|PubMed:16987817, ECO:0000269|PubMed:17187778, ECO:0000269|PubMed:17360499, ECO:0000269|PubMed:29712776, ECO:0000269|PubMed:33547280}.; FUNCTION: (Microbial infection) Cellular cofactor of human T-cell leukemia virus type I (HTLV-1) Rex protein and of human immunodeficiency virus type 1 (HIV-1) Rev protein, essential for mRNA export of retroviral transcripts. {ECO:0000269|PubMed:8253832}. |
P63261 | ACTG1 | Y240 | ochoa | Actin, cytoplasmic 2 (EC 3.6.4.-) (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. May play a role in the repair of noise-induced stereocilia gaps thereby maintains hearing sensitivity following loud noise damage (By similarity). {ECO:0000250|UniProtKB:P63260, ECO:0000305|PubMed:29581253}. |
P63267 | ACTG2 | Y241 | ochoa | Actin, gamma-enteric smooth muscle (EC 3.6.4.-) (Alpha-actin-3) (Gamma-2-actin) (Smooth muscle gamma-actin) [Cleaved into: Actin, gamma-enteric smooth muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P68032 | ACTC1 | Y242 | ochoa | Actin, alpha cardiac muscle 1 (EC 3.6.4.-) (Alpha-cardiac actin) [Cleaved into: Actin, alpha cardiac muscle 1, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P68104 | EEF1A1 | T22 | ochoa | Elongation factor 1-alpha 1 (EF-1-alpha-1) (EC 3.6.5.-) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7) | Translation elongation factor that catalyzes the GTP-dependent binding of aminoacyl-tRNA (aa-tRNA) to the A-site of ribosomes during the elongation phase of protein synthesis (PubMed:26593721, PubMed:26651998, PubMed:36123449, PubMed:36264623, PubMed:36638793). Base pairing between the mRNA codon and the aa-tRNA anticodon promotes GTP hydrolysis, releasing the aa-tRNA from EEF1A1 and allowing its accommodation into the ribosome (PubMed:26593721, PubMed:26651998, PubMed:36123449, PubMed:36264623, PubMed:36638793). The growing protein chain is subsequently transferred from the P-site peptidyl tRNA to the A-site aa-tRNA, extending it by one amino acid through ribosome-catalyzed peptide bond formation (PubMed:26593721, PubMed:26651998, PubMed:36123449, PubMed:36264623). Also plays a role in the positive regulation of IFNG transcription in T-helper 1 cells as part of an IFNG promoter-binding complex with TXK and PARP1 (PubMed:17177976). Also plays a role in cytoskeleton organization by promoting actin bundling (By similarity). {ECO:0000250|UniProtKB:P68105, ECO:0000269|PubMed:17177976, ECO:0000269|PubMed:26593721, ECO:0000269|PubMed:26651998, ECO:0000269|PubMed:36123449, ECO:0000269|PubMed:36264623, ECO:0000269|PubMed:36638793}.; FUNCTION: (Microbial infection) Required for the translation of viral proteins and viral replication during human coronavirus SARS-CoV-2 infection. {ECO:0000269|PubMed:33495306}. |
P68133 | ACTA1 | Y242 | ochoa | Actin, alpha skeletal muscle (EC 3.6.4.-) (Alpha-actin-1) [Cleaved into: Actin, alpha skeletal muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P68363 | TUBA1B | T223 | ochoa | Tubulin alpha-1B chain (EC 3.6.5.-) (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain] | Tubulin is the major constituent of microtubules, protein filaments consisting of alpha- and beta-tubulin heterodimers (PubMed:38305685, PubMed:34996871, PubMed:38609661). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms (PubMed:38305685, PubMed:34996871, PubMed:38609661). Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin (PubMed:34996871, PubMed:38609661). {ECO:0000269|PubMed:34996871, ECO:0000269|PubMed:38305685, ECO:0000269|PubMed:38609661}. |
P68366 | TUBA4A | T223 | ochoa | Tubulin alpha-4A chain (EC 3.6.5.-) (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P78527 | PRKDC | T516 | ochoa | DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (Ser-473 kinase) (S473K) (p460) | Serine/threonine-protein kinase that acts as a molecular sensor for DNA damage (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234). Involved in DNA non-homologous end joining (NHEJ) required for double-strand break (DSB) repair and V(D)J recombination (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234, PubMed:34352203). Must be bound to DNA to express its catalytic properties (PubMed:11955432). Promotes processing of hairpin DNA structures in V(D)J recombination by activation of the hairpin endonuclease artemis (DCLRE1C) (PubMed:11955432). Recruited by XRCC5 and XRCC6 to DNA ends and is required to (1) protect and align broken ends of DNA, thereby preventing their degradation, (2) and sequester the DSB for repair by NHEJ (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326, PubMed:33854234). Acts as a scaffold protein to aid the localization of DNA repair proteins to the site of damage (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). The assembly of the DNA-PK complex at DNA ends is also required for the NHEJ ligation step (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). Found at the ends of chromosomes, suggesting a further role in the maintenance of telomeric stability and the prevention of chromosomal end fusion (By similarity). Also involved in modulation of transcription (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome (PubMed:32103174). Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome (PubMed:32103174). Recognizes the substrate consensus sequence [ST]-Q (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). Phosphorylates 'Ser-139' of histone variant H2AX, thereby regulating DNA damage response mechanism (PubMed:14627815, PubMed:16046194). Phosphorylates ASF1A, DCLRE1C, c-Abl/ABL1, histone H1, HSPCA, c-jun/JUN, p53/TP53, PARP1, POU2F1, DHX9, FH, SRF, NHEJ1/XLF, XRCC1, XRCC4, XRCC5, XRCC6, WRN, MYC and RFA2 (PubMed:10026262, PubMed:10467406, PubMed:11889123, PubMed:12509254, PubMed:14599745, PubMed:14612514, PubMed:14704337, PubMed:15177042, PubMed:1597196, PubMed:16397295, PubMed:18644470, PubMed:2247066, PubMed:2507541, PubMed:26237645, PubMed:26666690, PubMed:28712728, PubMed:29478807, PubMed:30247612, PubMed:8407951, PubMed:8464713, PubMed:9139719, PubMed:9362500). Can phosphorylate C1D not only in the presence of linear DNA but also in the presence of supercoiled DNA (PubMed:9679063). Ability to phosphorylate p53/TP53 in the presence of supercoiled DNA is dependent on C1D (PubMed:9363941). Acts as a regulator of the phosphatidylinositol 3-kinase/protein kinase B signal transduction by mediating phosphorylation of 'Ser-473' of protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), promoting their activation (PubMed:15262962). Contributes to the determination of the circadian period length by antagonizing phosphorylation of CRY1 'Ser-588' and increasing CRY1 protein stability, most likely through an indirect mechanism (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). Also regulates the cGAS-STING pathway by catalyzing phosphorylation of CGAS, thereby impairing CGAS oligomerization and activation (PubMed:33273464). Also regulates the cGAS-STING pathway by mediating phosphorylation of PARP1 (PubMed:35460603). {ECO:0000250|UniProtKB:P97313, ECO:0000269|PubMed:10026262, ECO:0000269|PubMed:10467406, ECO:0000269|PubMed:11889123, ECO:0000269|PubMed:11955432, ECO:0000269|PubMed:12509254, ECO:0000269|PubMed:12649176, ECO:0000269|PubMed:14599745, ECO:0000269|PubMed:14612514, ECO:0000269|PubMed:14627815, ECO:0000269|PubMed:14704337, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:15177042, ECO:0000269|PubMed:15262962, ECO:0000269|PubMed:15574326, ECO:0000269|PubMed:1597196, ECO:0000269|PubMed:16046194, ECO:0000269|PubMed:16397295, ECO:0000269|PubMed:18644470, ECO:0000269|PubMed:2247066, ECO:0000269|PubMed:2507541, ECO:0000269|PubMed:26237645, ECO:0000269|PubMed:26666690, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:29478807, ECO:0000269|PubMed:30247612, ECO:0000269|PubMed:32103174, ECO:0000269|PubMed:33273464, ECO:0000269|PubMed:33854234, ECO:0000269|PubMed:34352203, ECO:0000269|PubMed:35460603, ECO:0000269|PubMed:8407951, ECO:0000269|PubMed:8464713, ECO:0000269|PubMed:9139719, ECO:0000269|PubMed:9362500, ECO:0000269|PubMed:9363941, ECO:0000269|PubMed:9679063}. |
Q05639 | EEF1A2 | T22 | ochoa | Elongation factor 1-alpha 2 (EF-1-alpha-2) (EC 3.6.5.-) (Eukaryotic elongation factor 1 A-2) (eEF1A-2) (Statin-S1) | Translation elongation factor that catalyzes the GTP-dependent binding of aminoacyl-tRNA (aa-tRNA) to the A-site of ribosomes during the elongation phase of protein synthesis. Base pairing between the mRNA codon and the aa-tRNA anticodon promotes GTP hydrolysis, releasing the aa-tRNA from EEF1A1 and allowing its accommodation into the ribosome (By similarity). The growing protein chain is subsequently transferred from the P-site peptidyl tRNA to the A-site aa-tRNA, extending it by one amino acid through ribosome-catalyzed peptide bond formation (By similarity). {ECO:0000250|UniProtKB:P68104, ECO:0000250|UniProtKB:Q71V39}. |
Q08043 | ACTN3 | T185 | ochoa | Alpha-actinin-3 (Alpha-actinin skeletal muscle isoform 3) (F-actin cross-linking protein) | F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein. |
Q13057 | COASY | T173 | ochoa | Bifunctional coenzyme A synthase (CoA synthase) (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)] | Bifunctional enzyme that catalyzes the fourth and fifth sequential steps of CoA biosynthetic pathway. The fourth reaction is catalyzed by the phosphopantetheine adenylyltransferase, coded by the coaD domain; the fifth reaction is catalyzed by the dephospho-CoA kinase, coded by the coaE domain. May act as a point of CoA biosynthesis regulation. {ECO:0000269|PubMed:11923312, ECO:0000269|PubMed:24360804}. |
Q13203 | MYBPH | T183 | ochoa | Myosin-binding protein H (MyBP-H) (H-protein) | Binds to myosin; probably involved in interaction with thick myofilaments in the A-band. |
Q14324 | MYBPC2 | T849 | ochoa | Myosin-binding protein C, fast-type (Fast MyBP-C) (C-protein, skeletal muscle fast isoform) | Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role. |
Q15797 | SMAD1 | T322 | ochoa|psp | Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (JV4-1) (Mad-related protein 1) (SMAD family member 1) (SMAD 1) (Smad1) (hSMAD1) (Transforming growth factor-beta-signaling protein 1) (BSP-1) | Transcriptional modulator that plays a role in various cellular processes, including embryonic development, cell differentiation, and tissue homeostasis (PubMed:9335504). Upon BMP ligand binding to their receptors at the cell surface, is phosphorylated by activated type I BMP receptors (BMPRIs) and associates with SMAD4 to form a heteromeric complex which translocates into the nucleus acting as transcription factor (PubMed:33667543). In turn, the hetero-trimeric complex recognizes cis-regulatory elements containing Smad Binding Elements (SBEs) to modulate the outcome of the signaling network (PubMed:33667543). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1. Positively regulates BMP4-induced expression of odontogenic development regulator MSX1 following IPO7-mediated nuclear import (By similarity). {ECO:0000250|UniProtKB:P70340, ECO:0000269|PubMed:12097147, ECO:0000269|PubMed:33667543, ECO:0000269|PubMed:9335504}. |
Q29RF7 | PDS5A | T1160 | ochoa | Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112) (SCC-112) | Probable regulator of sister chromatid cohesion in mitosis which may stabilize cohesin complex association with chromatin. May couple sister chromatid cohesion during mitosis to DNA replication. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. {ECO:0000269|PubMed:15855230, ECO:0000269|PubMed:19907496}. |
Q562R1 | ACTBL2 | Y241 | ochoa | Beta-actin-like protein 2 (Kappa-actin) | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. {ECO:0000250}. |
Q5VTE0 | EEF1A1P5 | T22 | ochoa | Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5) | This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. {ECO:0000250}. |
Q6IS14 | EIF5AL1 | T76 | ochoa | Eukaryotic translation initiation factor 5A-1-like (eIF-5A-1-like) (eIF-5A1-like) (Eukaryotic initiation factor 5A isoform 1-like) | Translation factor that promotes translation elongation and termination, particularly upon ribosome stalling at specific amino acid sequence contexts (By similarity). Binds between the exit (E) and peptidyl (P) site of the ribosome and promotes rescue of stalled ribosome: specifically required for efficient translation of polyproline-containing peptides as well as other motifs that stall the ribosome. Acts as a ribosome quality control (RQC) cofactor by joining the RQC complex to facilitate peptidyl transfer during CAT tailing step (By similarity). Also involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity (By similarity). {ECO:0000250|UniProtKB:P23301, ECO:0000250|UniProtKB:P63241}. |
Q6PEY2 | TUBA3E | T223 | ochoa | Tubulin alpha-3E chain (EC 3.6.5.-) (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q6S8J3 | POTEE | Y940 | ochoa | POTE ankyrin domain family member E (ANKRD26-like family C member 1A) (Prostate, ovary, testis-expressed protein on chromosome 2) (POTE-2) | None |
Q71U36 | TUBA1A | T223 | ochoa | Tubulin alpha-1A chain (EC 3.6.5.-) (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q7Z3D4 | LYSMD3 | T54 | ochoa | LysM and putative peptidoglycan-binding domain-containing protein 3 | Essential for Golgi structural integrity. {ECO:0000269|PubMed:29851555}. |
Q7Z3J3 | RGPD4 | S1482 | ochoa | RanBP2-like and GRIP domain-containing protein 4 | None |
Q8TDB8 | SLC2A14 | T256 | ochoa | Solute carrier family 2, facilitated glucose transporter member 14 (Glucose transporter type 14) (GLUT-14) | Hexose transporter that can mediate the transport of glucose and dehydroascorbate across the cell membrane. {ECO:0000269|PubMed:28971850}. |
Q96BK5 | PINX1 | T170 | ochoa | PIN2/TERF1-interacting telomerase inhibitor 1 (Liver-related putative tumor suppressor) (Pin2-interacting protein X1) (Protein 67-11-3) (TRF1-interacting protein 1) | Microtubule-binding protein essential for faithful chromosome segregation. Mediates TRF1 and TERT accumulation in nucleolus and enhances TRF1 binding to telomeres. Inhibits telomerase activity. May inhibit cell proliferation and act as tumor suppressor. {ECO:0000269|PubMed:15381700, ECO:0000269|PubMed:17198684, ECO:0000269|PubMed:19117989, ECO:0000269|PubMed:19265708, ECO:0000269|PubMed:19393617, ECO:0000269|PubMed:19553660}. |
Q96I24 | FUBP3 | T43 | ochoa | Far upstream element-binding protein 3 (FUSE-binding protein 3) | May interact with single-stranded DNA from the far-upstream element (FUSE). May activate gene expression. |
Q99501 | GAS2L1 | T220 | ochoa | GAS2-like protein 1 (GAS2-related protein on chromosome 22) (Growth arrest-specific protein 2-like 1) | Involved in the cross-linking of microtubules and microfilaments (PubMed:12584248, PubMed:24706950). Regulates microtubule dynamics and stability by interacting with microtubule plus-end tracking proteins, such as MAPRE1, to regulate microtubule growth along actin stress fibers (PubMed:24706950). {ECO:0000269|PubMed:12584248, ECO:0000269|PubMed:24706950}. |
Q99666 | RGPD5 | S1481 | ochoa | RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63) | None |
Q99717 | SMAD5 | T322 | ochoa | Mothers against decapentaplegic homolog 5 (MAD homolog 5) (Mothers against DPP homolog 5) (JV5-1) (SMAD family member 5) (SMAD 5) (Smad5) (hSmad5) | Transcriptional regulator that plays a role in various cellular processes including embryonic development, cell differentiation, angiogenesis and tissue homeostasis (PubMed:12064918, PubMed:16516194). Upon BMP ligand binding to their receptors at the cell surface, is phosphorylated by activated type I BMP receptors (BMPRIs) and associates with SMAD4 to form a heteromeric complex which translocates into the nucleus acting as transcription factor (PubMed:9442019). In turn, the hetero-trimeric complex recognizes cis-regulatory elements containing Smad Binding Elements (SBEs) to modulate the outcome of the signaling network (PubMed:33510867). Non-phosphorylated SMAD5 has a cytoplasmic role in energy metabolism regulation by promoting mitochondrial respiration and glycolysis in response to cytoplasmic pH changes (PubMed:28675158). Mechanistically, interacts with hexokinase 1/HK1 and thereby accelerates glycolysis (PubMed:28675158). {ECO:0000269|PubMed:12064918, ECO:0000269|PubMed:16516194, ECO:0000269|PubMed:28675158, ECO:0000269|PubMed:33510867, ECO:0000269|PubMed:9442019}. |
Q9BQE3 | TUBA1C | T223 | ochoa | Tubulin alpha-1C chain (EC 3.6.5.-) (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q9BY89 | KIAA1671 | T1231 | ochoa | Uncharacterized protein KIAA1671 | None |
Q9BYX7 | POTEKP | Y240 | ochoa | Putative beta-actin-like protein 3 (Kappa-actin) (POTE ankyrin domain family member K) | None |
Q9GZV4 | EIF5A2 | T76 | ochoa | Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (eIF-5A2) (Eukaryotic initiation factor 5A isoform 2) | Translation factor that promotes translation elongation and termination, particularly upon ribosome stalling at specific amino acid sequence contexts (PubMed:14622290). Binds between the exit (E) and peptidyl (P) site of the ribosome and promotes rescue of stalled ribosome: specifically required for efficient translation of polyproline-containing peptides as well as other motifs that stall the ribosome. Acts as a ribosome quality control (RQC) cofactor by joining the RQC complex to facilitate peptidyl transfer during CAT tailing step (By similarity). Also involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity (By similarity). {ECO:0000250|UniProtKB:P23301, ECO:0000250|UniProtKB:P63241, ECO:0000269|PubMed:14622290}. |
Q9H329 | EPB41L4B | T424 | ochoa | Band 4.1-like protein 4B (Erythrocyte membrane protein band 4.1-like 4B) (FERM-containing protein CG1) (Protein EHM2) | Up-regulates the activity of the Rho guanine nucleotide exchange factor ARHGEF18 (By similarity). Involved in the regulation of the circumferential actomyosin belt in epithelial cells (PubMed:22006950). Promotes cellular adhesion, migration and motility in vitro and may play a role in wound healing (PubMed:23664528). May have a role in mediating cytoskeletal changes associated with steroid-induced cell differentiation (PubMed:14521927). {ECO:0000250|UniProtKB:Q9JMC8, ECO:0000269|PubMed:14521927, ECO:0000269|PubMed:22006950, ECO:0000269|PubMed:23664528}. |
Q9NRP7 | STK36 | T152 | ochoa | Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog) | Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors (PubMed:10806483). Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization (PubMed:10806483). GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur (PubMed:10806483). Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function. Essential for construction of the central pair apparatus of motile cilia. {ECO:0000269|PubMed:10806483, ECO:0000269|PubMed:28543983}. |
Q9NY65 | TUBA8 | T223 | ochoa | Tubulin alpha-8 chain (EC 3.6.5.-) (Alpha-tubulin 8) (Tubulin alpha chain-like 2) [Cleaved into: Dephenylalaninated tubulin alpha-8 chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q9UL51 | HCN2 | T576 | psp | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2) | Hyperpolarization-activated ion channel that is permeable to sodium and potassium ions. Displays lower selectivity for K(+) over Na(+) ions (PubMed:10228147, PubMed:22006928). Contributes to the native pacemaker currents in heart (If) and in neurons (Ih) (PubMed:10228147, PubMed:10524219). Can also transport ammonium in the distal nephron (By similarity). Involved in the initiation of neuropathic pain in sensory neurons (By similarity). {ECO:0000250|UniProtKB:Q9JKA9, ECO:0000269|PubMed:10228147, ECO:0000269|PubMed:10524219, ECO:0000269|PubMed:22006928}. |
Q9UQR1 | ZNF148 | T632 | ochoa | Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89) | Involved in transcriptional regulation. Represses the transcription of a number of genes including gastrin, stromelysin and enolase. Binds to the G-rich box in the enhancer region of these genes. |
Q9Y4B5 | MTCL1 | T1747 | ochoa | Microtubule cross-linking factor 1 (Coiled-coil domain-containing protein 165) (PAR-1-interacting protein) (SOGA family member 2) | Microtubule-associated factor involved in the late phase of epithelial polarization and microtubule dynamics regulation (PubMed:23902687). Plays a role in the development and maintenance of non-centrosomal microtubule bundles at the lateral membrane in polarized epithelial cells (PubMed:23902687). Required for faithful chromosome segregation during mitosis (PubMed:33587225). {ECO:0000269|PubMed:23902687, ECO:0000269|PubMed:33587225}. |
P07900 | HSP90AA1 | T88 | Sugiyama | Heat shock protein HSP 90-alpha (EC 3.6.4.10) (Heat shock 86 kDa) (HSP 86) (HSP86) (Heat shock protein family C member 1) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38) | Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity which is essential for its chaperone activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function (PubMed:11274138, PubMed:12526792, PubMed:15577939, PubMed:15937123, PubMed:27353360, PubMed:29127155). Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself (PubMed:29127155). Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle (PubMed:26991466, PubMed:27295069). Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 (PubMed:12526792). Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels (PubMed:25973397). In the first place, they alter the steady-state levels of certain transcription factors in response to various physiological cues (PubMed:25973397). Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment (PubMed:25973397). Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression (PubMed:25973397). Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:11276205). Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation (PubMed:24613385). Mediates the association of TOMM70 with IRF3 or TBK1 in mitochondrial outer membrane which promotes host antiviral response (PubMed:20628368, PubMed:25609812). {ECO:0000269|PubMed:11274138, ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:15577939, ECO:0000269|PubMed:15937123, ECO:0000269|PubMed:20628368, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:25609812, ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:29127155, ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.; FUNCTION: (Microbial infection) Seems to interfere with N.meningitidis NadA-mediated invasion of human cells. Decreasing HSP90 levels increases adhesion and entry of E.coli expressing NadA into human Chang cells; increasing its levels leads to decreased adhesion and invasion. {ECO:0000305|PubMed:22066472}. |
P08238 | HSP90AB1 | T83 | Sugiyama | Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84) (Heat shock protein family C member 3) | Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function (PubMed:16478993, PubMed:19696785). Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself. Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle (PubMed:26991466, PubMed:27295069). Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels. They first alter the steady-state levels of certain transcription factors in response to various physiological cues. Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment. Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression (PubMed:25973397). Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation (PubMed:24613385). Promotes cell differentiation by chaperoning BIRC2 and thereby protecting from auto-ubiquitination and degradation by the proteasomal machinery (PubMed:18239673). Main chaperone involved in the phosphorylation/activation of the STAT1 by chaperoning both JAK2 and PRKCE under heat shock and in turn, activates its own transcription (PubMed:20353823). Involved in the translocation into ERGIC (endoplasmic reticulum-Golgi intermediate compartment) of leaderless cargos (lacking the secretion signal sequence) such as the interleukin 1/IL-1; the translocation process is mediated by the cargo receptor TMED10 (PubMed:32272059). {ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:19696785, ECO:0000269|PubMed:20353823, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:32272059, ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.; FUNCTION: (Microbial infection) Binding to N.meningitidis NadA stimulates monocytes (PubMed:21949862). Seems to interfere with N.meningitidis NadA-mediated invasion of human cells (Probable). {ECO:0000269|PubMed:21949862, ECO:0000305|PubMed:22066472}. |
Q58FG1 | HSP90AA4P | T28 | Sugiyama | Putative heat shock protein HSP 90-alpha A4 (Heat shock 90 kDa protein 1 alpha-like 2) (Heat shock protein 90-alpha D) (Heat shock protein 90Ad) | Putative molecular chaperone that may promote the maturation, structural maintenance and proper regulation of specific target proteins. {ECO:0000250}. |
P30281 | CCND3 | T128 | Sugiyama | G1/S-specific cyclin-D3 | Regulatory component of the cyclin D3-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition (PubMed:8114739). Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase (PubMed:8114739). Hypophosphorylates RB1 in early G(1) phase (PubMed:8114739). Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals (PubMed:8114739). Component of the ternary complex, cyclin D3/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex (PubMed:16782892). Shows transcriptional coactivator activity with ATF5 independently of CDK4 (PubMed:15358120). {ECO:0000269|PubMed:15358120, ECO:0000269|PubMed:16782892, ECO:0000269|PubMed:8114739}. |
P15313 | ATP6V1B1 | T323 | Sugiyama | V-type proton ATPase subunit B, kidney isoform (V-ATPase subunit B 1) (Endomembrane proton pump 58 kDa subunit) (Vacuolar proton pump subunit B 1) | Non-catalytic subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (PubMed:16769747). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (PubMed:32001091). Essential for the proper assembly and activity of V-ATPase (PubMed:16769747). In renal intercalated cells, mediates secretion of protons (H+) into the urine thereby ensuring correct urinary acidification (PubMed:16769747). Required for optimal olfactory function by mediating the acidification of the nasal olfactory epithelium (By similarity). {ECO:0000250|UniProtKB:Q91YH6, ECO:0000269|PubMed:16769747, ECO:0000303|PubMed:32001091}. |
P21281 | ATP6V1B2 | T329 | Sugiyama | V-type proton ATPase subunit B, brain isoform (V-ATPase subunit B 2) (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2) | Non-catalytic subunit of the V1 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (PubMed:33065002). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (PubMed:32001091). In renal intercalated cells, can partially compensate the lack of ATP6V1B1 and mediate secretion of protons (H+) into the urine under base-line conditions but not in conditions of acid load (By similarity). {ECO:0000250|UniProtKB:P62814, ECO:0000269|PubMed:33065002, ECO:0000303|PubMed:32001091}. |
Q06187 | BTK | T602 | Sugiyama | Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) | Non-receptor tyrosine kinase indispensable for B lymphocyte development, differentiation and signaling (PubMed:19290921). Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation (PubMed:19290921). After BCR engagement and activation at the plasma membrane, phosphorylates PLCG2 at several sites, igniting the downstream signaling pathway through calcium mobilization, followed by activation of the protein kinase C (PKC) family members (PubMed:11606584). PLCG2 phosphorylation is performed in close cooperation with the adapter protein B-cell linker protein BLNK (PubMed:11606584). BTK acts as a platform to bring together a diverse array of signaling proteins and is implicated in cytokine receptor signaling pathways (PubMed:16517732, PubMed:17932028). Plays an important role in the function of immune cells of innate as well as adaptive immunity, as a component of the Toll-like receptors (TLR) pathway (PubMed:16517732). The TLR pathway acts as a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense (PubMed:16517732). Especially, is a critical molecule in regulating TLR9 activation in splenic B-cells (PubMed:16517732, PubMed:17932028). Within the TLR pathway, induces tyrosine phosphorylation of TIRAP which leads to TIRAP degradation (PubMed:16415872). BTK also plays a critical role in transcription regulation (PubMed:19290921). Induces the activity of NF-kappa-B, which is involved in regulating the expression of hundreds of genes (PubMed:19290921). BTK is involved on the signaling pathway linking TLR8 and TLR9 to NF-kappa-B (PubMed:19290921). Acts as an activator of NLRP3 inflammasome assembly by mediating phosphorylation of NLRP3 (PubMed:34554188). Transiently phosphorylates transcription factor GTF2I on tyrosine residues in response to BCR (PubMed:9012831). GTF2I then translocates to the nucleus to bind regulatory enhancer elements to modulate gene expression (PubMed:9012831). ARID3A and NFAT are other transcriptional target of BTK (PubMed:16738337). BTK is required for the formation of functional ARID3A DNA-binding complexes (PubMed:16738337). There is however no evidence that BTK itself binds directly to DNA (PubMed:16738337). BTK has a dual role in the regulation of apoptosis (PubMed:9751072). Plays a role in STING1-mediated induction of type I interferon (IFN) response by phosphorylating DDX41 (PubMed:25704810). {ECO:0000269|PubMed:11606584, ECO:0000269|PubMed:16415872, ECO:0000269|PubMed:16517732, ECO:0000269|PubMed:16738337, ECO:0000269|PubMed:17932028, ECO:0000269|PubMed:25704810, ECO:0000269|PubMed:34554188, ECO:0000269|PubMed:9012831, ECO:0000303|PubMed:19290921, ECO:0000303|PubMed:9751072}. |
O15212 | PFDN6 | T75 | Sugiyama | Prefoldin subunit 6 (Protein Ke2) | Binds specifically to cytosolic chaperonin (c-CPN) and transfers target proteins to it. Binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins. {ECO:0000269|PubMed:9630229}. |
Q13442 | PDAP1 | T92 | Sugiyama | 28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1) | Enhances PDGFA-stimulated cell growth in fibroblasts, but inhibits the mitogenic effect of PDGFB. {ECO:0000250}. |
Q5S007 | LRRK2 | T1849 | EPSD|PSP | Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin) | Serine/threonine-protein kinase which phosphorylates a broad range of proteins involved in multiple processes such as neuronal plasticity, innate immunity, autophagy, and vesicle trafficking (PubMed:17114044, PubMed:20949042, PubMed:21850687, PubMed:22012985, PubMed:23395371, PubMed:24687852, PubMed:25201882, PubMed:26014385, PubMed:26824392, PubMed:27830463, PubMed:28720718, PubMed:29125462, PubMed:29127255, PubMed:29212815, PubMed:30398148, PubMed:30635421). Is a key regulator of RAB GTPases by regulating the GTP/GDP exchange and interaction partners of RABs through phosphorylation (PubMed:26824392, PubMed:28720718, PubMed:29125462, PubMed:29127255, PubMed:29212815, PubMed:30398148, PubMed:30635421). Phosphorylates RAB3A, RAB3B, RAB3C, RAB3D, RAB5A, RAB5B, RAB5C, RAB8A, RAB8B, RAB10, RAB12, RAB29, RAB35, and RAB43 (PubMed:23395371, PubMed:26824392, PubMed:28720718, PubMed:29125462, PubMed:29127255, PubMed:29212815, PubMed:30398148, PubMed:30635421, PubMed:38127736). Regulates the RAB3IP-catalyzed GDP/GTP exchange for RAB8A through the phosphorylation of 'Thr-72' on RAB8A (PubMed:26824392). Inhibits the interaction between RAB8A and GDI1 and/or GDI2 by phosphorylating 'Thr-72' on RAB8A (PubMed:26824392). Regulates primary ciliogenesis through phosphorylation of RAB8A and RAB10, which promotes SHH signaling in the brain (PubMed:29125462, PubMed:30398148). Together with RAB29, plays a role in the retrograde trafficking pathway for recycling proteins, such as mannose-6-phosphate receptor (M6PR), between lysosomes and the Golgi apparatus in a retromer-dependent manner (PubMed:23395371). Regulates neuronal process morphology in the intact central nervous system (CNS) (PubMed:17114044). Plays a role in synaptic vesicle trafficking (PubMed:24687852). Plays an important role in recruiting SEC16A to endoplasmic reticulum exit sites (ERES) and in regulating ER to Golgi vesicle-mediated transport and ERES organization (PubMed:25201882). Positively regulates autophagy through a calcium-dependent activation of the CaMKK/AMPK signaling pathway (PubMed:22012985). The process involves activation of nicotinic acid adenine dinucleotide phosphate (NAADP) receptors, increase in lysosomal pH, and calcium release from lysosomes (PubMed:22012985). Phosphorylates PRDX3 (PubMed:21850687). By phosphorylating APP on 'Thr-743', which promotes the production and the nuclear translocation of the APP intracellular domain (AICD), regulates dopaminergic neuron apoptosis (PubMed:28720718). Acts as a positive regulator of innate immunity by mediating phosphorylation of RIPK2 downstream of NOD1 and NOD2, thereby enhancing RIPK2 activation (PubMed:27830463). Independent of its kinase activity, inhibits the proteasomal degradation of MAPT, thus promoting MAPT oligomerization and secretion (PubMed:26014385). In addition, has GTPase activity via its Roc domain which regulates LRRK2 kinase activity (PubMed:18230735, PubMed:26824392, PubMed:28720718, PubMed:29125462, PubMed:29212815). Recruited by RAB29/RAB7L1 to overloaded lysosomes where it phosphorylates and stabilizes RAB8A and RAB10 which promote lysosomal content release and suppress lysosomal enlargement through the EHBP1 and EHBP1L1 effector proteins (PubMed:30209220, PubMed:38227290). {ECO:0000269|PubMed:17114044, ECO:0000269|PubMed:18230735, ECO:0000269|PubMed:20949042, ECO:0000269|PubMed:21850687, ECO:0000269|PubMed:22012985, ECO:0000269|PubMed:23395371, ECO:0000269|PubMed:24687852, ECO:0000269|PubMed:25201882, ECO:0000269|PubMed:26014385, ECO:0000269|PubMed:26824392, ECO:0000269|PubMed:27830463, ECO:0000269|PubMed:28720718, ECO:0000269|PubMed:29125462, ECO:0000269|PubMed:29127255, ECO:0000269|PubMed:29212815, ECO:0000269|PubMed:30209220, ECO:0000269|PubMed:30398148, ECO:0000269|PubMed:30635421, ECO:0000269|PubMed:38127736, ECO:0000269|PubMed:38227290}. |
Q9Y5S2 | CDC42BPB | T858 | Sugiyama | Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) | Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2 (PubMed:21457715, PubMed:21949762). In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration (PubMed:18854160). Phosphorylates PPP1R12A (PubMed:21457715). In concert with FAM89B/LRAP25 mediates the targeting of LIMK1 to the lamellipodium resulting in its activation and subsequent phosphorylation of CFL1 which is important for lamellipodial F-actin regulation (By similarity). {ECO:0000250|UniProtKB:Q7TT50, ECO:0000269|PubMed:18854160, ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:21949762}. |
Q92630 | DYRK2 | T468 | Sugiyama | Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) | Serine/threonine-protein kinase involved in the regulation of the mitotic cell cycle, cell proliferation, apoptosis, organization of the cytoskeleton and neurite outgrowth. Functions in part via its role in ubiquitin-dependent proteasomal protein degradation. Functions downstream of ATM and phosphorylates p53/TP53 at 'Ser-46', and thereby contributes to the induction of apoptosis in response to DNA damage. Phosphorylates NFATC1, and thereby inhibits its accumulation in the nucleus and its transcription factor activity. Phosphorylates EIF2B5 at 'Ser-544', enabling its subsequent phosphorylation and inhibition by GSK3B. Likewise, phosphorylation of NFATC1, CRMP2/DPYSL2 and CRMP4/DPYSL3 promotes their subsequent phosphorylation by GSK3B. May play a general role in the priming of GSK3 substrates. Inactivates GYS1 by phosphorylation at 'Ser-641', and potentially also a second phosphorylation site, thus regulating glycogen synthesis. Mediates EDVP E3 ligase complex formation and is required for the phosphorylation and subsequent degradation of KATNA1. Phosphorylates TERT at 'Ser-457', promoting TERT ubiquitination by the EDVP complex. Phosphorylates SIAH2, and thereby increases its ubiquitin ligase activity. Promotes the proteasomal degradation of MYC and JUN, and thereby regulates progress through the mitotic cell cycle and cell proliferation. Promotes proteasomal degradation of GLI2 and GLI3, and thereby plays a role in smoothened and sonic hedgehog signaling. Plays a role in cytoskeleton organization and neurite outgrowth via its phosphorylation of DCX and DPYSL2. Phosphorylates CRMP2/DPYSL2, CRMP4/DPYSL3, DCX, EIF2B5, EIF4EBP1, GLI2, GLI3, GYS1, JUN, MDM2, MYC, NFATC1, p53/TP53, TAU/MAPT and KATNA1. Can phosphorylate histone H1, histone H3 and histone H2B (in vitro). Can phosphorylate CARHSP1 (in vitro). {ECO:0000269|PubMed:11311121, ECO:0000269|PubMed:12588975, ECO:0000269|PubMed:14593110, ECO:0000269|PubMed:15910284, ECO:0000269|PubMed:16511445, ECO:0000269|PubMed:16611631, ECO:0000269|PubMed:17349958, ECO:0000269|PubMed:18455992, ECO:0000269|PubMed:18599021, ECO:0000269|PubMed:19287380, ECO:0000269|PubMed:22307329, ECO:0000269|PubMed:22878263, ECO:0000269|PubMed:23362280, ECO:0000269|PubMed:9748265}. |
Q96PY6 | NEK1 | T24 | Sugiyama | Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55) | Phosphorylates serines and threonines, but also appears to possess tyrosine kinase activity (PubMed:20230784). Involved in DNA damage checkpoint control and for proper DNA damage repair (PubMed:20230784). In response to injury that includes DNA damage, NEK1 phosphorylates VDAC1 to limit mitochondrial cell death (PubMed:20230784). May be implicated in the control of meiosis (By similarity). Involved in cilium assembly (PubMed:21211617). {ECO:0000250|UniProtKB:P51954, ECO:0000269|PubMed:20230784, ECO:0000269|PubMed:21211617}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-389958 | Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 2.486900e-14 | 13.604 |
R-HSA-190828 | Gap junction trafficking | 6.987744e-13 | 12.156 |
R-HSA-190840 | Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | 1.020184e-12 | 11.991 |
R-HSA-437239 | Recycling pathway of L1 | 1.207590e-12 | 11.918 |
R-HSA-190872 | Transport of connexons to the plasma membrane | 1.449174e-12 | 11.839 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 1.929235e-12 | 11.715 |
R-HSA-157858 | Gap junction trafficking and regulation | 1.709966e-12 | 11.767 |
R-HSA-389977 | Post-chaperonin tubulin folding pathway | 2.797540e-12 | 11.553 |
R-HSA-389960 | Formation of tubulin folding intermediates by CCT/TriC | 1.175349e-11 | 10.930 |
R-HSA-9646399 | Aggrephagy | 1.073763e-11 | 10.969 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 1.256228e-11 | 10.901 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 1.547962e-11 | 10.810 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 2.780642e-11 | 10.556 |
R-HSA-9619483 | Activation of AMPK downstream of NMDARs | 3.140321e-11 | 10.503 |
R-HSA-9668328 | Sealing of the nuclear envelope (NE) by ESCRT-III | 9.195833e-11 | 10.036 |
R-HSA-190861 | Gap junction assembly | 1.359309e-10 | 9.867 |
R-HSA-390466 | Chaperonin-mediated protein folding | 2.620918e-10 | 9.582 |
R-HSA-389957 | Prefoldin mediated transfer of substrate to CCT/TriC | 4.707772e-10 | 9.327 |
R-HSA-391251 | Protein folding | 4.673690e-10 | 9.330 |
R-HSA-8955332 | Carboxyterminal post-translational modifications of tubulin | 1.335861e-09 | 8.874 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 3.814851e-09 | 8.419 |
R-HSA-373760 | L1CAM interactions | 4.641846e-09 | 8.333 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 5.783399e-09 | 8.238 |
R-HSA-9612973 | Autophagy | 5.640399e-09 | 8.249 |
R-HSA-438064 | Post NMDA receptor activation events | 5.292913e-09 | 8.276 |
R-HSA-9663891 | Selective autophagy | 5.783399e-09 | 8.238 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 6.614864e-09 | 8.179 |
R-HSA-983189 | Kinesins | 6.866862e-09 | 8.163 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 2.121701e-08 | 7.673 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 2.165505e-08 | 7.664 |
R-HSA-69275 | G2/M Transition | 2.966303e-08 | 7.528 |
R-HSA-453274 | Mitotic G2-G2/M phases | 3.270193e-08 | 7.485 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 3.783694e-08 | 7.422 |
R-HSA-68877 | Mitotic Prometaphase | 4.154649e-08 | 7.381 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 4.923647e-08 | 7.308 |
R-HSA-9833482 | PKR-mediated signaling | 4.923647e-08 | 7.308 |
R-HSA-9913351 | Formation of the dystrophin-glycoprotein complex (DGC) | 8.859315e-08 | 7.053 |
R-HSA-2467813 | Separation of Sister Chromatids | 1.054797e-07 | 6.977 |
R-HSA-422475 | Axon guidance | 1.344003e-07 | 6.872 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 2.154034e-07 | 6.667 |
R-HSA-6807878 | COPI-mediated anterograde transport | 2.154034e-07 | 6.667 |
R-HSA-9675108 | Nervous system development | 3.128371e-07 | 6.505 |
R-HSA-1632852 | Macroautophagy | 3.516827e-07 | 6.454 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 7.075548e-07 | 6.150 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 7.299920e-07 | 6.137 |
R-HSA-5620924 | Intraflagellar transport | 9.763853e-07 | 6.010 |
R-HSA-68882 | Mitotic Anaphase | 1.103244e-06 | 5.957 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 1.145560e-06 | 5.941 |
R-HSA-2132295 | MHC class II antigen presentation | 1.353865e-06 | 5.868 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 1.887348e-06 | 5.724 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 2.386563e-06 | 5.622 |
R-HSA-9764561 | Regulation of CDH1 Function | 2.291546e-06 | 5.640 |
R-HSA-5617833 | Cilium Assembly | 3.441134e-06 | 5.463 |
R-HSA-390522 | Striated Muscle Contraction | 3.885419e-06 | 5.411 |
R-HSA-9609690 | HCMV Early Events | 4.317483e-06 | 5.365 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 5.264442e-06 | 5.279 |
R-HSA-69278 | Cell Cycle, Mitotic | 6.309570e-06 | 5.200 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 7.913921e-06 | 5.102 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 9.150629e-06 | 5.039 |
R-HSA-68886 | M Phase | 2.005665e-05 | 4.698 |
R-HSA-9609646 | HCMV Infection | 2.598009e-05 | 4.585 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 2.620876e-05 | 4.582 |
R-HSA-156842 | Eukaryotic Translation Elongation | 2.890486e-05 | 4.539 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 3.948687e-05 | 4.404 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 4.207441e-05 | 4.376 |
R-HSA-5610787 | Hedgehog 'off' state | 4.607912e-05 | 4.336 |
R-HSA-1640170 | Cell Cycle | 6.796456e-05 | 4.168 |
R-HSA-2262752 | Cellular responses to stress | 7.667126e-05 | 4.115 |
R-HSA-1266738 | Developmental Biology | 8.202926e-05 | 4.086 |
R-HSA-9735869 | SARS-CoV-1 modulates host translation machinery | 9.820327e-05 | 4.008 |
R-HSA-112315 | Transmission across Chemical Synapses | 1.595252e-04 | 3.797 |
R-HSA-9824446 | Viral Infection Pathways | 2.532192e-04 | 3.597 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 2.792813e-04 | 3.554 |
R-HSA-5358351 | Signaling by Hedgehog | 2.796685e-04 | 3.553 |
R-HSA-8953897 | Cellular responses to stimuli | 3.036240e-04 | 3.518 |
R-HSA-9613829 | Chaperone Mediated Autophagy | 3.327265e-04 | 3.478 |
R-HSA-397014 | Muscle contraction | 3.877425e-04 | 3.411 |
R-HSA-72649 | Translation initiation complex formation | 4.687752e-04 | 3.329 |
R-HSA-112316 | Neuronal System | 4.964164e-04 | 3.304 |
R-HSA-913531 | Interferon Signaling | 5.244253e-04 | 3.280 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 5.276588e-04 | 3.278 |
R-HSA-189200 | Cellular hexose transport | 5.880709e-04 | 3.231 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 5.916238e-04 | 3.228 |
R-HSA-1500931 | Cell-Cell communication | 7.058286e-04 | 3.151 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 8.541768e-04 | 3.068 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 8.541768e-04 | 3.068 |
R-HSA-201451 | Signaling by BMP | 9.431046e-04 | 3.025 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 1.517513e-03 | 2.819 |
R-HSA-199991 | Membrane Trafficking | 1.534730e-03 | 2.814 |
R-HSA-5336415 | Uptake and function of diphtheria toxin | 1.555385e-03 | 2.808 |
R-HSA-196025 | Formation of annular gap junctions | 1.875047e-03 | 2.727 |
R-HSA-3371511 | HSF1 activation | 2.002536e-03 | 2.698 |
R-HSA-392499 | Metabolism of proteins | 2.006961e-03 | 2.697 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 2.206031e-03 | 2.656 |
R-HSA-190873 | Gap junction degradation | 2.223202e-03 | 2.653 |
R-HSA-204626 | Hypusine synthesis from eIF5A-lysine | 2.223202e-03 | 2.653 |
R-HSA-9834752 | Respiratory syncytial virus genome replication | 2.223202e-03 | 2.653 |
R-HSA-156902 | Peptide chain elongation | 2.414164e-03 | 2.617 |
R-HSA-418990 | Adherens junctions interactions | 2.516483e-03 | 2.599 |
R-HSA-9820962 | Assembly and release of respiratory syncytial virus (RSV) virions | 2.599522e-03 | 2.585 |
R-HSA-5653656 | Vesicle-mediated transport | 2.703722e-03 | 2.568 |
R-HSA-9856651 | MITF-M-dependent gene expression | 2.868138e-03 | 2.542 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 3.079115e-03 | 2.512 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 3.248294e-03 | 2.488 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 3.311775e-03 | 2.480 |
R-HSA-5663205 | Infectious disease | 3.433360e-03 | 2.464 |
R-HSA-9711097 | Cellular response to starvation | 3.493118e-03 | 2.457 |
R-HSA-446203 | Asparagine N-linked glycosylation | 3.935133e-03 | 2.405 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 5.121653e-03 | 2.291 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 5.739982e-03 | 2.241 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 5.739982e-03 | 2.241 |
R-HSA-399954 | Sema3A PAK dependent Axon repulsion | 5.430884e-03 | 2.265 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 5.121653e-03 | 2.291 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 5.137439e-03 | 2.289 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 5.553514e-03 | 2.255 |
R-HSA-168255 | Influenza Infection | 5.710614e-03 | 2.243 |
R-HSA-446353 | Cell-extracellular matrix interactions | 5.430884e-03 | 2.265 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 4.829984e-03 | 2.316 |
R-HSA-421270 | Cell-cell junction organization | 4.725709e-03 | 2.326 |
R-HSA-109582 | Hemostasis | 6.238188e-03 | 2.205 |
R-HSA-72737 | Cap-dependent Translation Initiation | 6.757938e-03 | 2.170 |
R-HSA-72613 | Eukaryotic Translation Initiation | 6.757938e-03 | 2.170 |
R-HSA-446728 | Cell junction organization | 7.398533e-03 | 2.131 |
R-HSA-3371556 | Cellular response to heat stress | 7.692456e-03 | 2.114 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 8.039360e-03 | 2.095 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 8.039360e-03 | 2.095 |
R-HSA-8854518 | AURKA Activation by TPX2 | 8.991543e-03 | 2.046 |
R-HSA-373753 | Nephrin family interactions | 9.196547e-03 | 2.036 |
R-HSA-196836 | Vitamin C (ascorbate) metabolism | 9.910392e-03 | 2.004 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 9.910392e-03 | 2.004 |
R-HSA-162582 | Signal Transduction | 1.041984e-02 | 1.982 |
R-HSA-9825892 | Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | 1.064809e-02 | 1.973 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 1.104239e-02 | 1.957 |
R-HSA-5619043 | Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | 1.136211e-02 | 1.945 |
R-HSA-9857377 | Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autopha... | 1.140935e-02 | 1.943 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 1.146109e-02 | 1.941 |
R-HSA-380287 | Centrosome maturation | 1.223138e-02 | 1.913 |
R-HSA-597592 | Post-translational protein modification | 1.387153e-02 | 1.858 |
R-HSA-9022699 | MECP2 regulates neuronal receptors and channels | 1.468435e-02 | 1.833 |
R-HSA-72766 | Translation | 1.480021e-02 | 1.830 |
R-HSA-9665230 | Drug resistance in ERBB2 KD mutants | 2.259651e-02 | 1.646 |
R-HSA-9652282 | Drug-mediated inhibition of ERBB2 signaling | 2.259651e-02 | 1.646 |
R-HSA-9665251 | Resistance of ERBB2 KD mutants to lapatinib | 2.259651e-02 | 1.646 |
R-HSA-9665250 | Resistance of ERBB2 KD mutants to AEE788 | 2.259651e-02 | 1.646 |
R-HSA-9665737 | Drug resistance in ERBB2 TMD/JMD mutants | 2.259651e-02 | 1.646 |
R-HSA-9665233 | Resistance of ERBB2 KD mutants to trastuzumab | 2.259651e-02 | 1.646 |
R-HSA-9665247 | Resistance of ERBB2 KD mutants to osimertinib | 2.259651e-02 | 1.646 |
R-HSA-9665246 | Resistance of ERBB2 KD mutants to neratinib | 2.259651e-02 | 1.646 |
R-HSA-9665249 | Resistance of ERBB2 KD mutants to afatinib | 2.259651e-02 | 1.646 |
R-HSA-9665245 | Resistance of ERBB2 KD mutants to tesevatinib | 2.259651e-02 | 1.646 |
R-HSA-9665244 | Resistance of ERBB2 KD mutants to sapitinib | 2.259651e-02 | 1.646 |
R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells | 1.737424e-02 | 1.760 |
R-HSA-9954714 | PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 1.996703e-02 | 1.700 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 2.048902e-02 | 1.688 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 1.945251e-02 | 1.711 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 1.555919e-02 | 1.808 |
R-HSA-77387 | Insulin receptor recycling | 1.645591e-02 | 1.784 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 1.605994e-02 | 1.794 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 1.665584e-02 | 1.778 |
R-HSA-9679506 | SARS-CoV Infections | 1.745372e-02 | 1.758 |
R-HSA-9694516 | SARS-CoV-2 Infection | 1.939548e-02 | 1.712 |
R-HSA-1474244 | Extracellular matrix organization | 1.557291e-02 | 1.808 |
R-HSA-9954716 | ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ri... | 2.265189e-02 | 1.645 |
R-HSA-72764 | Eukaryotic Translation Termination | 2.321134e-02 | 1.634 |
R-HSA-917977 | Transferrin endocytosis and recycling | 2.438526e-02 | 1.613 |
R-HSA-9678108 | SARS-CoV-1 Infection | 2.550709e-02 | 1.593 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 2.656792e-02 | 1.576 |
R-HSA-2408557 | Selenocysteine synthesis | 2.672532e-02 | 1.573 |
R-HSA-192823 | Viral mRNA Translation | 2.795648e-02 | 1.554 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 2.858326e-02 | 1.544 |
R-HSA-9820965 | Respiratory syncytial virus (RSV) genome replication, transcription and translat... | 2.882663e-02 | 1.540 |
R-HSA-3371568 | Attenuation phase | 2.998390e-02 | 1.523 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 3.116485e-02 | 1.506 |
R-HSA-74160 | Gene expression (Transcription) | 3.173674e-02 | 1.498 |
R-HSA-5674135 | MAP2K and MAPK activation | 3.235303e-02 | 1.490 |
R-HSA-9656223 | Signaling by RAF1 mutants | 3.235303e-02 | 1.490 |
R-HSA-1296061 | HCN channels | 3.370462e-02 | 1.472 |
R-HSA-9754119 | Drug-mediated inhibition of CDK4/CDK6 activity | 3.370462e-02 | 1.472 |
R-HSA-3928662 | EPHB-mediated forward signaling | 3.603964e-02 | 1.443 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 3.813658e-02 | 1.419 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 3.858325e-02 | 1.414 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 3.858325e-02 | 1.414 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 3.858325e-02 | 1.414 |
R-HSA-6802949 | Signaling by RAS mutants | 3.858325e-02 | 1.414 |
R-HSA-376176 | Signaling by ROBO receptors | 3.885129e-02 | 1.411 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 3.988012e-02 | 1.399 |
R-HSA-8937144 | Aryl hydrocarbon receptor signalling | 4.468784e-02 | 1.350 |
R-HSA-3371571 | HSF1-dependent transactivation | 4.522948e-02 | 1.345 |
R-HSA-5339562 | Uptake and actions of bacterial toxins | 4.660618e-02 | 1.332 |
R-HSA-194138 | Signaling by VEGF | 4.664614e-02 | 1.331 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 4.780490e-02 | 1.321 |
R-HSA-9639288 | Amino acids regulate mTORC1 | 4.799819e-02 | 1.319 |
R-HSA-445355 | Smooth Muscle Contraction | 4.799819e-02 | 1.319 |
R-HSA-114608 | Platelet degranulation | 4.828618e-02 | 1.316 |
R-HSA-8857538 | PTK6 promotes HIF1A stabilization | 5.013306e-02 | 1.300 |
R-HSA-5653890 | Lactose synthesis | 5.013306e-02 | 1.300 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 5.226391e-02 | 1.282 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 5.424675e-02 | 1.266 |
R-HSA-2470946 | Cohesin Loading onto Chromatin | 5.554757e-02 | 1.255 |
R-HSA-426117 | Cation-coupled Chloride cotransporters | 5.554757e-02 | 1.255 |
R-HSA-2468052 | Establishment of Sister Chromatid Cohesion | 7.160860e-02 | 1.145 |
R-HSA-390450 | Folding of actin by CCT/TriC | 7.160860e-02 | 1.145 |
R-HSA-3000484 | Scavenging by Class F Receptors | 8.739943e-02 | 1.058 |
R-HSA-9661069 | Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 9.260377e-02 | 1.033 |
R-HSA-8964315 | G beta:gamma signalling through BTK | 1.029245e-01 | 0.987 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 7.873548e-02 | 1.104 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 9.411674e-02 | 1.026 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 6.581988e-02 | 1.182 |
R-HSA-6802957 | Oncogenic MAPK signaling | 9.942331e-02 | 1.003 |
R-HSA-192905 | vRNP Assembly | 7.690201e-02 | 1.114 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 8.216556e-02 | 1.085 |
R-HSA-9634285 | Constitutive Signaling by Overexpressed ERBB2 | 8.739943e-02 | 1.058 |
R-HSA-9659787 | Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 9.260377e-02 | 1.033 |
R-HSA-9933947 | Formation of the non-canonical BAF (ncBAF) complex | 9.260377e-02 | 1.033 |
R-HSA-9948299 | Ribosome-associated quality control | 5.962400e-02 | 1.225 |
R-HSA-428359 | Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RN... | 7.160860e-02 | 1.145 |
R-HSA-196783 | Coenzyme A biosynthesis | 1.131292e-01 | 0.946 |
R-HSA-9664417 | Leishmania phagocytosis | 6.147039e-02 | 1.211 |
R-HSA-9664407 | Parasite infection | 6.147039e-02 | 1.211 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 6.147039e-02 | 1.211 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 7.708001e-02 | 1.113 |
R-HSA-8876725 | Protein methylation | 1.029245e-01 | 0.987 |
R-HSA-9933937 | Formation of the canonical BAF (cBAF) complex | 9.777875e-02 | 1.010 |
R-HSA-3270619 | IRF3-mediated induction of type I IFN | 1.029245e-01 | 0.987 |
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 1.029245e-01 | 0.987 |
R-HSA-9933939 | Formation of the polybromo-BAF (pBAF) complex | 9.777875e-02 | 1.010 |
R-HSA-9659379 | Sensory processing of sound | 8.889690e-02 | 1.051 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 7.057347e-02 | 1.151 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 9.446785e-02 | 1.025 |
R-HSA-9658195 | Leishmania infection | 9.431102e-02 | 1.025 |
R-HSA-9824443 | Parasitic Infection Pathways | 9.431102e-02 | 1.025 |
R-HSA-1643685 | Disease | 8.167776e-02 | 1.088 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 6.428983e-02 | 1.192 |
R-HSA-9006936 | Signaling by TGFB family members | 8.241940e-02 | 1.084 |
R-HSA-917937 | Iron uptake and transport | 8.207979e-02 | 1.086 |
R-HSA-2408522 | Selenoamino acid metabolism | 8.671900e-02 | 1.062 |
R-HSA-163841 | Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | 1.030070e-01 | 0.987 |
R-HSA-9679191 | Potential therapeutics for SARS | 7.209521e-02 | 1.142 |
R-HSA-9013694 | Signaling by NOTCH4 | 8.040214e-02 | 1.095 |
R-HSA-373755 | Semaphorin interactions | 6.271380e-02 | 1.203 |
R-HSA-73857 | RNA Polymerase II Transcription | 6.220294e-02 | 1.206 |
R-HSA-168256 | Immune System | 1.079548e-01 | 0.967 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 1.121182e-01 | 0.950 |
R-HSA-1222556 | ROS and RNS production in phagocytes | 8.040214e-02 | 1.095 |
R-HSA-212436 | Generic Transcription Pathway | 6.299040e-02 | 1.201 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 1.156288e-01 | 0.937 |
R-HSA-74752 | Signaling by Insulin receptor | 1.158202e-01 | 0.936 |
R-HSA-2682334 | EPH-Ephrin signaling | 1.158202e-01 | 0.936 |
R-HSA-8953854 | Metabolism of RNA | 1.163878e-01 | 0.934 |
R-HSA-5637812 | Signaling by EGFRvIII in Cancer | 1.181884e-01 | 0.927 |
R-HSA-5637810 | Constitutive Signaling by EGFRvIII | 1.181884e-01 | 0.927 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 1.214310e-01 | 0.916 |
R-HSA-9665348 | Signaling by ERBB2 ECD mutants | 1.232190e-01 | 0.909 |
R-HSA-167242 | Abortive elongation of HIV-1 transcript in the absence of Tat | 1.282212e-01 | 0.892 |
R-HSA-844456 | The NLRP3 inflammasome | 1.282212e-01 | 0.892 |
R-HSA-1834941 | STING mediated induction of host immune responses | 1.282212e-01 | 0.892 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 1.331952e-01 | 0.876 |
R-HSA-1236382 | Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 1.381412e-01 | 0.860 |
R-HSA-5637815 | Signaling by Ligand-Responsive EGFR Variants in Cancer | 1.381412e-01 | 0.860 |
R-HSA-5602498 | MyD88 deficiency (TLR2/4) | 1.381412e-01 | 0.860 |
R-HSA-6798695 | Neutrophil degranulation | 1.388111e-01 | 0.858 |
R-HSA-438066 | Unblocking of NMDA receptors, glutamate binding and activation | 1.430592e-01 | 0.844 |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | 1.430592e-01 | 0.844 |
R-HSA-5603041 | IRAK4 deficiency (TLR2/4) | 1.430592e-01 | 0.844 |
R-HSA-9617324 | Negative regulation of NMDA receptor-mediated neuronal transmission | 1.430592e-01 | 0.844 |
R-HSA-168249 | Innate Immune System | 1.473230e-01 | 0.832 |
R-HSA-6804115 | TP53 regulates transcription of additional cell cycle genes whose exact role in ... | 1.479495e-01 | 0.830 |
R-HSA-211000 | Gene Silencing by RNA | 1.484277e-01 | 0.828 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 1.504013e-01 | 0.823 |
R-HSA-77075 | RNA Pol II CTD phosphorylation and interaction with CE | 1.528121e-01 | 0.816 |
R-HSA-167160 | RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 1.528121e-01 | 0.816 |
R-HSA-1280218 | Adaptive Immune System | 1.557675e-01 | 0.808 |
R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants | 1.576473e-01 | 0.802 |
R-HSA-429947 | Deadenylation of mRNA | 1.576473e-01 | 0.802 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 1.576473e-01 | 0.802 |
R-HSA-8863678 | Neurodegenerative Diseases | 1.576473e-01 | 0.802 |
R-HSA-5683057 | MAPK family signaling cascades | 1.587579e-01 | 0.799 |
R-HSA-9620244 | Long-term potentiation | 1.624552e-01 | 0.789 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 1.624552e-01 | 0.789 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 1.624552e-01 | 0.789 |
R-HSA-5601884 | PIWI-interacting RNA (piRNA) biogenesis | 1.624552e-01 | 0.789 |
R-HSA-1643713 | Signaling by EGFR in Cancer | 1.672360e-01 | 0.777 |
R-HSA-8934593 | Regulation of RUNX1 Expression and Activity | 1.672360e-01 | 0.777 |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | 1.719898e-01 | 0.764 |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | 1.719898e-01 | 0.764 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 1.719898e-01 | 0.764 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 1.722789e-01 | 0.764 |
R-HSA-72312 | rRNA processing | 1.750874e-01 | 0.757 |
R-HSA-167287 | HIV elongation arrest and recovery | 1.767167e-01 | 0.753 |
R-HSA-167290 | Pausing and recovery of HIV elongation | 1.767167e-01 | 0.753 |
R-HSA-113418 | Formation of the Early Elongation Complex | 1.767167e-01 | 0.753 |
R-HSA-167158 | Formation of the HIV-1 Early Elongation Complex | 1.767167e-01 | 0.753 |
R-HSA-622312 | Inflammasomes | 1.767167e-01 | 0.753 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 1.775137e-01 | 0.751 |
R-HSA-72086 | mRNA Capping | 1.814169e-01 | 0.741 |
R-HSA-9664565 | Signaling by ERBB2 KD Mutants | 1.814169e-01 | 0.741 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 1.860906e-01 | 0.730 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 1.860906e-01 | 0.730 |
R-HSA-2424491 | DAP12 signaling | 1.860906e-01 | 0.730 |
R-HSA-9687139 | Aberrant regulation of mitotic cell cycle due to RB1 defects | 1.860906e-01 | 0.730 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 1.860906e-01 | 0.730 |
R-HSA-1474151 | Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 1.860906e-01 | 0.730 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 1.907379e-01 | 0.720 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 1.907379e-01 | 0.720 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 1.953589e-01 | 0.709 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 1.999539e-01 | 0.699 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 1.999539e-01 | 0.699 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 1.999539e-01 | 0.699 |
R-HSA-397795 | G-protein beta:gamma signalling | 1.999539e-01 | 0.699 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 1.999539e-01 | 0.699 |
R-HSA-5675482 | Regulation of necroptotic cell death | 1.999539e-01 | 0.699 |
R-HSA-9733709 | Cardiogenesis | 1.999539e-01 | 0.699 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 2.045228e-01 | 0.689 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 2.045228e-01 | 0.689 |
R-HSA-5696394 | DNA Damage Recognition in GG-NER | 2.045228e-01 | 0.689 |
R-HSA-8964539 | Glutamate and glutamine metabolism | 2.045228e-01 | 0.689 |
R-HSA-199220 | Vitamin B5 (pantothenate) metabolism | 2.045228e-01 | 0.689 |
R-HSA-9843745 | Adipogenesis | 2.053259e-01 | 0.688 |
R-HSA-203615 | eNOS activation | 2.090660e-01 | 0.680 |
R-HSA-180746 | Nuclear import of Rev protein | 2.090660e-01 | 0.680 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 2.135835e-01 | 0.670 |
R-HSA-425407 | SLC-mediated transmembrane transport | 2.170969e-01 | 0.663 |
R-HSA-9018519 | Estrogen-dependent gene expression | 2.178409e-01 | 0.662 |
R-HSA-8941326 | RUNX2 regulates bone development | 2.180755e-01 | 0.661 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 2.199338e-01 | 0.658 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 2.225421e-01 | 0.653 |
R-HSA-202131 | Metabolism of nitric oxide: NOS3 activation and regulation | 2.269835e-01 | 0.644 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 2.269835e-01 | 0.644 |
R-HSA-5213460 | RIPK1-mediated regulated necrosis | 2.269835e-01 | 0.644 |
R-HSA-9958790 | SLC-mediated transport of inorganic anions | 2.269835e-01 | 0.644 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 2.313997e-01 | 0.636 |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | 2.313997e-01 | 0.636 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 2.313997e-01 | 0.636 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 2.325256e-01 | 0.634 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 2.346292e-01 | 0.630 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 2.357910e-01 | 0.627 |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | 2.357910e-01 | 0.627 |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | 2.357910e-01 | 0.627 |
R-HSA-167169 | HIV Transcription Elongation | 2.357910e-01 | 0.627 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 2.357910e-01 | 0.627 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 2.357910e-01 | 0.627 |
R-HSA-5260271 | Diseases of Immune System | 2.357910e-01 | 0.627 |
R-HSA-5602358 | Diseases associated with the TLR signaling cascade | 2.357910e-01 | 0.627 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 2.357910e-01 | 0.627 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 2.357910e-01 | 0.627 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 2.366359e-01 | 0.626 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 2.401575e-01 | 0.620 |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | 2.401575e-01 | 0.620 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 2.401575e-01 | 0.620 |
R-HSA-69242 | S Phase | 2.451633e-01 | 0.611 |
R-HSA-69236 | G1 Phase | 2.573781e-01 | 0.589 |
R-HSA-69231 | Cyclin D associated events in G1 | 2.573781e-01 | 0.589 |
R-HSA-2172127 | DAP12 interactions | 2.573781e-01 | 0.589 |
R-HSA-5673001 | RAF/MAP kinase cascade | 2.595101e-01 | 0.586 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 2.616225e-01 | 0.582 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 2.616225e-01 | 0.582 |
R-HSA-162587 | HIV Life Cycle | 2.641685e-01 | 0.578 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 2.658430e-01 | 0.575 |
R-HSA-9664424 | Cell recruitment (pro-inflammatory response) | 2.658430e-01 | 0.575 |
R-HSA-9660826 | Purinergic signaling in leishmaniasis infection | 2.658430e-01 | 0.575 |
R-HSA-9861718 | Regulation of pyruvate metabolism | 2.658430e-01 | 0.575 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 2.702904e-01 | 0.568 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 2.742125e-01 | 0.562 |
R-HSA-5619102 | SLC transporter disorders | 2.852967e-01 | 0.545 |
R-HSA-72187 | mRNA 3'-end processing | 2.906693e-01 | 0.537 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 2.906693e-01 | 0.537 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 2.906693e-01 | 0.537 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 2.947255e-01 | 0.531 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 2.947255e-01 | 0.531 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 2.963108e-01 | 0.528 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 3.107222e-01 | 0.508 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 3.107222e-01 | 0.508 |
R-HSA-194441 | Metabolism of non-coding RNA | 3.185854e-01 | 0.497 |
R-HSA-191859 | snRNP Assembly | 3.185854e-01 | 0.497 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 3.185854e-01 | 0.497 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 3.224837e-01 | 0.491 |
R-HSA-8873719 | RAB geranylgeranylation | 3.224837e-01 | 0.491 |
R-HSA-1227986 | Signaling by ERBB2 | 3.224837e-01 | 0.491 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 3.263599e-01 | 0.486 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 3.263599e-01 | 0.486 |
R-HSA-6784531 | tRNA processing in the nucleus | 3.302142e-01 | 0.481 |
R-HSA-983712 | Ion channel transport | 3.335984e-01 | 0.477 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 3.340466e-01 | 0.476 |
R-HSA-8848021 | Signaling by PTK6 | 3.340466e-01 | 0.476 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 3.378574e-01 | 0.471 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 3.398424e-01 | 0.469 |
R-HSA-167172 | Transcription of the HIV genome | 3.528859e-01 | 0.452 |
R-HSA-5218859 | Regulated Necrosis | 3.528859e-01 | 0.452 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 3.602732e-01 | 0.443 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 3.639355e-01 | 0.439 |
R-HSA-8978934 | Metabolism of cofactors | 3.639355e-01 | 0.439 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 3.669370e-01 | 0.435 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 3.675770e-01 | 0.435 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 3.675770e-01 | 0.435 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 3.747983e-01 | 0.426 |
R-HSA-8852135 | Protein ubiquitination | 3.783784e-01 | 0.422 |
R-HSA-1169408 | ISG15 antiviral mechanism | 3.783784e-01 | 0.422 |
R-HSA-5689603 | UCH proteinases | 3.819381e-01 | 0.418 |
R-HSA-416482 | G alpha (12/13) signalling events | 3.889972e-01 | 0.410 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 3.889972e-01 | 0.410 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 3.994366e-01 | 0.399 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 4.096995e-01 | 0.388 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 4.130818e-01 | 0.384 |
R-HSA-162906 | HIV Infection | 4.131079e-01 | 0.384 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 4.164449e-01 | 0.380 |
R-HSA-141424 | Amplification of signal from the kinetochores | 4.164449e-01 | 0.380 |
R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs | 4.164449e-01 | 0.380 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 4.197889e-01 | 0.377 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 4.197889e-01 | 0.377 |
R-HSA-70268 | Pyruvate metabolism | 4.231140e-01 | 0.374 |
R-HSA-9645723 | Diseases of programmed cell death | 4.264203e-01 | 0.370 |
R-HSA-1236974 | ER-Phagosome pathway | 4.297077e-01 | 0.367 |
R-HSA-8939211 | ESR-mediated signaling | 4.327814e-01 | 0.364 |
R-HSA-157118 | Signaling by NOTCH | 4.386165e-01 | 0.358 |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messenge... | 4.458677e-01 | 0.351 |
R-HSA-9837999 | Mitochondrial protein degradation | 4.490449e-01 | 0.348 |
R-HSA-5619115 | Disorders of transmembrane transporters | 4.521063e-01 | 0.345 |
R-HSA-1296071 | Potassium Channels | 4.584689e-01 | 0.339 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 4.584689e-01 | 0.339 |
R-HSA-422356 | Regulation of insulin secretion | 4.646627e-01 | 0.333 |
R-HSA-5688426 | Deubiquitination | 4.673003e-01 | 0.330 |
R-HSA-3214847 | HATs acetylate histones | 4.677333e-01 | 0.330 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 4.707865e-01 | 0.327 |
R-HSA-70171 | Glycolysis | 4.707865e-01 | 0.327 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 4.738224e-01 | 0.324 |
R-HSA-9842860 | Regulation of endogenous retroelements | 4.768410e-01 | 0.322 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 4.768410e-01 | 0.322 |
R-HSA-9734767 | Developmental Cell Lineages | 4.822473e-01 | 0.317 |
R-HSA-5696398 | Nucleotide Excision Repair | 4.887451e-01 | 0.311 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 4.945964e-01 | 0.306 |
R-HSA-9700206 | Signaling by ALK in cancer | 4.945964e-01 | 0.306 |
R-HSA-1236975 | Antigen processing-Cross presentation | 4.974971e-01 | 0.303 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 4.982943e-01 | 0.303 |
R-HSA-1483249 | Inositol phosphate metabolism | 5.089362e-01 | 0.293 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 5.113677e-01 | 0.291 |
R-HSA-382551 | Transport of small molecules | 5.130417e-01 | 0.290 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 5.228734e-01 | 0.282 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 5.278130e-01 | 0.278 |
R-HSA-1592230 | Mitochondrial biogenesis | 5.283381e-01 | 0.277 |
R-HSA-70326 | Glucose metabolism | 5.283381e-01 | 0.277 |
R-HSA-9007101 | Rab regulation of trafficking | 5.283381e-01 | 0.277 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 5.337409e-01 | 0.273 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 5.337409e-01 | 0.273 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 5.337409e-01 | 0.273 |
R-HSA-68875 | Mitotic Prophase | 5.364193e-01 | 0.270 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 5.417305e-01 | 0.266 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 5.417305e-01 | 0.266 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 5.443635e-01 | 0.264 |
R-HSA-162909 | Host Interactions of HIV factors | 5.469815e-01 | 0.262 |
R-HSA-163685 | Integration of energy metabolism | 5.845122e-01 | 0.233 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 6.100638e-01 | 0.215 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 6.145396e-01 | 0.211 |
R-HSA-2173782 | Binding and Uptake of Ligands by Scavenger Receptors | 6.189646e-01 | 0.208 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 6.255081e-01 | 0.204 |
R-HSA-9610379 | HCMV Late Events | 6.340601e-01 | 0.198 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 6.361677e-01 | 0.196 |
R-HSA-5633007 | Regulation of TP53 Activity | 6.403471e-01 | 0.194 |
R-HSA-73894 | DNA Repair | 6.417715e-01 | 0.193 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 6.460420e-01 | 0.190 |
R-HSA-72306 | tRNA processing | 6.624986e-01 | 0.179 |
R-HSA-5689880 | Ub-specific processing proteases | 6.683020e-01 | 0.175 |
R-HSA-9824439 | Bacterial Infection Pathways | 6.840004e-01 | 0.165 |
R-HSA-168898 | Toll-like Receptor Cascades | 7.011066e-01 | 0.154 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 7.062529e-01 | 0.151 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 7.211717e-01 | 0.142 |
R-HSA-72172 | mRNA Splicing | 7.243838e-01 | 0.140 |
R-HSA-5357801 | Programmed Cell Death | 7.259761e-01 | 0.139 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 7.573896e-01 | 0.121 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 7.594634e-01 | 0.119 |
R-HSA-3247509 | Chromatin modifying enzymes | 7.683957e-01 | 0.114 |
R-HSA-4839726 | Chromatin organization | 7.877176e-01 | 0.104 |
R-HSA-69620 | Cell Cycle Checkpoints | 7.985361e-01 | 0.098 |
R-HSA-416476 | G alpha (q) signalling events | 8.054436e-01 | 0.094 |
R-HSA-211945 | Phase I - Functionalization of compounds | 8.206633e-01 | 0.086 |
R-HSA-212165 | Epigenetic regulation of gene expression | 8.620421e-01 | 0.064 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 8.758100e-01 | 0.058 |
R-HSA-449147 | Signaling by Interleukins | 8.879564e-01 | 0.052 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 9.034398e-01 | 0.044 |
R-HSA-211859 | Biological oxidations | 9.576465e-01 | 0.019 |
R-HSA-388396 | GPCR downstream signalling | 9.905142e-01 | 0.004 |
R-HSA-372790 | Signaling by GPCR | 9.942476e-01 | 0.003 |
R-HSA-9709957 | Sensory Perception | 9.950540e-01 | 0.002 |
R-HSA-1430728 | Metabolism | 9.981563e-01 | 0.001 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
DMPK1 |
0.748 | 0.230 | -3 | 0.643 |
GAK |
0.744 | 0.066 | 1 | 0.773 |
DAPK2 |
0.743 | 0.199 | -3 | 0.714 |
CAMLCK |
0.741 | 0.218 | -2 | 0.817 |
DAPK3 |
0.740 | 0.217 | -3 | 0.662 |
LATS1 |
0.739 | 0.131 | -3 | 0.677 |
CLK3 |
0.738 | 0.269 | 1 | 0.771 |
SMMLCK |
0.737 | 0.193 | -3 | 0.690 |
NIK |
0.735 | 0.042 | -3 | 0.716 |
DAPK1 |
0.734 | 0.231 | -3 | 0.659 |
MOS |
0.734 | 0.195 | 1 | 0.842 |
PASK |
0.734 | 0.121 | -3 | 0.701 |
PKR |
0.734 | -0.040 | 1 | 0.709 |
VRK2 |
0.733 | -0.139 | 1 | 0.764 |
GCK |
0.733 | 0.004 | 1 | 0.720 |
ROCK2 |
0.733 | 0.159 | -3 | 0.643 |
CAMK1B |
0.732 | 0.138 | -3 | 0.724 |
TAK1 |
0.732 | -0.039 | 1 | 0.741 |
ALK2 |
0.732 | 0.114 | -2 | 0.607 |
ALK4 |
0.731 | 0.062 | -2 | 0.625 |
BMPR2 |
0.731 | -0.052 | -2 | 0.671 |
MEK1 |
0.730 | -0.069 | 2 | 0.637 |
TNIK |
0.730 | -0.009 | 3 | 0.849 |
KHS2 |
0.729 | 0.040 | 1 | 0.692 |
TAO2 |
0.729 | -0.051 | 2 | 0.636 |
KHS1 |
0.729 | 0.004 | 1 | 0.675 |
HPK1 |
0.729 | 0.023 | 1 | 0.696 |
EEF2K |
0.729 | 0.016 | 3 | 0.822 |
ICK |
0.729 | 0.087 | -3 | 0.709 |
MRCKA |
0.728 | 0.182 | -3 | 0.626 |
CDKL1 |
0.728 | 0.070 | -3 | 0.702 |
LRRK2 |
0.727 | -0.111 | 2 | 0.630 |
MINK |
0.727 | -0.053 | 1 | 0.688 |
HGK |
0.726 | -0.042 | 3 | 0.854 |
ROCK1 |
0.726 | 0.173 | -3 | 0.629 |
CLK4 |
0.726 | 0.217 | -3 | 0.660 |
ACVR2B |
0.726 | 0.139 | -2 | 0.592 |
SKMLCK |
0.725 | 0.173 | -2 | 0.781 |
PRPK |
0.725 | -0.054 | -1 | 0.627 |
BRAF |
0.725 | -0.091 | -4 | 0.675 |
TGFBR1 |
0.725 | 0.094 | -2 | 0.591 |
ALPHAK3 |
0.725 | 0.027 | -1 | 0.573 |
NLK |
0.725 | 0.016 | 1 | 0.736 |
PIM2 |
0.725 | 0.122 | -3 | 0.640 |
MST1 |
0.724 | -0.071 | 1 | 0.707 |
TAO3 |
0.724 | -0.043 | 1 | 0.726 |
PBK |
0.724 | -0.003 | 1 | 0.678 |
DLK |
0.724 | -0.040 | 1 | 0.785 |
ASK1 |
0.724 | -0.108 | 1 | 0.704 |
MRCKB |
0.724 | 0.181 | -3 | 0.619 |
BMPR1B |
0.724 | 0.136 | 1 | 0.837 |
MST3 |
0.723 | -0.013 | 2 | 0.629 |
AURB |
0.723 | 0.285 | -2 | 0.840 |
MEK5 |
0.722 | -0.157 | 2 | 0.617 |
ACVR2A |
0.722 | 0.091 | -2 | 0.587 |
LOK |
0.722 | -0.007 | -2 | 0.714 |
BIKE |
0.722 | -0.000 | 1 | 0.655 |
MAP3K15 |
0.722 | -0.114 | 1 | 0.697 |
PDK1 |
0.721 | -0.067 | 1 | 0.674 |
CLK2 |
0.721 | 0.273 | -3 | 0.643 |
PIM1 |
0.721 | 0.115 | -3 | 0.665 |
MST2 |
0.721 | -0.079 | 1 | 0.734 |
VRK1 |
0.720 | -0.152 | 2 | 0.603 |
NEK1 |
0.720 | -0.142 | 1 | 0.673 |
BMPR1A |
0.719 | 0.142 | 1 | 0.839 |
PIM3 |
0.719 | 0.120 | -3 | 0.691 |
MYLK4 |
0.719 | 0.229 | -2 | 0.824 |
P70S6KB |
0.719 | 0.139 | -3 | 0.671 |
PKCD |
0.718 | 0.101 | 2 | 0.594 |
MYO3B |
0.718 | -0.046 | 2 | 0.613 |
YSK4 |
0.717 | -0.088 | 1 | 0.715 |
TTK |
0.717 | -0.061 | -2 | 0.627 |
CAMKK1 |
0.717 | -0.145 | -2 | 0.599 |
RAF1 |
0.717 | -0.006 | 1 | 0.778 |
ATR |
0.717 | -0.019 | 1 | 0.715 |
CRIK |
0.717 | 0.118 | -3 | 0.604 |
MEKK6 |
0.717 | -0.123 | 1 | 0.698 |
MYO3A |
0.716 | -0.060 | 1 | 0.655 |
MEK2 |
0.716 | -0.173 | 2 | 0.593 |
AKT2 |
0.716 | 0.176 | -3 | 0.602 |
LKB1 |
0.716 | -0.128 | -3 | 0.638 |
AURC |
0.716 | 0.301 | -2 | 0.842 |
HASPIN |
0.716 | 0.051 | -1 | 0.604 |
CAMKK2 |
0.716 | -0.146 | -2 | 0.627 |
GRK6 |
0.715 | 0.071 | 1 | 0.861 |
HIPK1 |
0.715 | 0.080 | 1 | 0.596 |
MEKK2 |
0.715 | -0.152 | 2 | 0.577 |
SLK |
0.715 | -0.010 | -2 | 0.634 |
YSK1 |
0.715 | -0.095 | 2 | 0.582 |
MSK1 |
0.715 | 0.239 | -3 | 0.635 |
NEK11 |
0.715 | -0.126 | 1 | 0.710 |
MPSK1 |
0.714 | -0.059 | 1 | 0.660 |
ANKRD3 |
0.714 | -0.130 | 1 | 0.744 |
MEKK1 |
0.714 | -0.156 | 1 | 0.718 |
RSK2 |
0.714 | 0.170 | -3 | 0.671 |
OSR1 |
0.714 | -0.055 | 2 | 0.584 |
PKACB |
0.714 | 0.276 | -2 | 0.845 |
AURA |
0.713 | 0.286 | -2 | 0.813 |
CHAK2 |
0.713 | 0.005 | -1 | 0.617 |
CLK1 |
0.713 | 0.174 | -3 | 0.644 |
NEK8 |
0.713 | -0.120 | 2 | 0.604 |
PKN3 |
0.712 | 0.055 | -3 | 0.681 |
PRP4 |
0.712 | -0.011 | -3 | 0.641 |
SGK3 |
0.712 | 0.146 | -3 | 0.629 |
MEKK3 |
0.712 | -0.081 | 1 | 0.717 |
MAK |
0.712 | 0.090 | -2 | 0.698 |
CAMK2G |
0.711 | -0.001 | 2 | 0.652 |
SGK1 |
0.711 | 0.155 | -3 | 0.548 |
AAK1 |
0.710 | 0.014 | 1 | 0.552 |
AKT1 |
0.710 | 0.187 | -3 | 0.598 |
MST4 |
0.710 | 0.049 | 2 | 0.655 |
NEK4 |
0.710 | -0.171 | 1 | 0.660 |
CDC7 |
0.710 | 0.076 | 1 | 0.847 |
GRK7 |
0.710 | 0.061 | 1 | 0.828 |
ZAK |
0.710 | -0.149 | 1 | 0.727 |
COT |
0.709 | 0.090 | 2 | 0.657 |
DYRK3 |
0.709 | 0.150 | 1 | 0.582 |
TSSK2 |
0.709 | 0.013 | -5 | 0.676 |
PKACG |
0.709 | 0.216 | -2 | 0.849 |
RSK4 |
0.709 | 0.185 | -3 | 0.639 |
NEK5 |
0.709 | -0.213 | 1 | 0.689 |
SRPK1 |
0.709 | 0.134 | -3 | 0.661 |
P90RSK |
0.708 | 0.114 | -3 | 0.672 |
PLK1 |
0.708 | -0.019 | -2 | 0.641 |
JNK2 |
0.707 | -0.002 | 1 | 0.547 |
PKN2 |
0.707 | 0.080 | -3 | 0.680 |
PAK2 |
0.707 | 0.163 | -2 | 0.814 |
GRK5 |
0.707 | -0.054 | -3 | 0.691 |
PKG2 |
0.707 | 0.234 | -2 | 0.851 |
P38A |
0.707 | -0.014 | 1 | 0.593 |
BUB1 |
0.707 | 0.041 | -5 | 0.598 |
CDKL5 |
0.707 | 0.039 | -3 | 0.693 |
TAO1 |
0.707 | -0.084 | 1 | 0.634 |
GRK1 |
0.707 | 0.155 | -2 | 0.571 |
CDK14 |
0.707 | 0.043 | 1 | 0.582 |
NDR1 |
0.706 | 0.116 | -3 | 0.683 |
SRPK3 |
0.706 | 0.109 | -3 | 0.648 |
PAK1 |
0.706 | 0.175 | -2 | 0.817 |
DYRK2 |
0.706 | 0.063 | 1 | 0.575 |
MNK1 |
0.705 | 0.166 | -2 | 0.835 |
AMPKA1 |
0.705 | 0.001 | -3 | 0.684 |
DRAK1 |
0.705 | 0.041 | 1 | 0.735 |
PERK |
0.705 | -0.153 | -2 | 0.628 |
WNK1 |
0.705 | -0.007 | -2 | 0.704 |
MSK2 |
0.705 | 0.171 | -3 | 0.643 |
MLK2 |
0.705 | -0.177 | 2 | 0.603 |
DYRK1A |
0.704 | 0.060 | 1 | 0.630 |
JNK3 |
0.704 | -0.018 | 1 | 0.583 |
CAMK4 |
0.704 | 0.093 | -3 | 0.663 |
HIPK3 |
0.703 | 0.055 | 1 | 0.578 |
HRI |
0.703 | -0.162 | -2 | 0.646 |
MASTL |
0.703 | -0.195 | -2 | 0.639 |
PKACA |
0.703 | 0.252 | -2 | 0.833 |
DCAMKL1 |
0.702 | -0.013 | -3 | 0.642 |
P38B |
0.702 | -0.011 | 1 | 0.549 |
PRKX |
0.702 | 0.279 | -3 | 0.563 |
PDHK4 |
0.702 | -0.217 | 1 | 0.772 |
NUAK2 |
0.702 | -0.001 | -3 | 0.685 |
MLK1 |
0.702 | -0.094 | 2 | 0.601 |
TSSK1 |
0.702 | 0.009 | -3 | 0.696 |
WNK4 |
0.702 | -0.113 | -2 | 0.685 |
PLK3 |
0.701 | 0.013 | 2 | 0.614 |
ERK5 |
0.701 | -0.081 | 1 | 0.671 |
CDK5 |
0.701 | 0.013 | 1 | 0.617 |
CHK1 |
0.701 | -0.063 | -3 | 0.669 |
RIPK3 |
0.700 | -0.010 | 3 | 0.659 |
DCAMKL2 |
0.700 | -0.020 | -3 | 0.664 |
NEK2 |
0.700 | -0.104 | 2 | 0.584 |
STLK3 |
0.700 | -0.175 | 1 | 0.690 |
CDK10 |
0.700 | 0.077 | 1 | 0.558 |
MOK |
0.700 | 0.037 | 1 | 0.564 |
RIPK1 |
0.700 | -0.101 | 1 | 0.670 |
MTOR |
0.699 | -0.051 | 1 | 0.718 |
PKCA |
0.699 | 0.045 | 2 | 0.539 |
PINK1 |
0.699 | -0.099 | 1 | 0.701 |
TGFBR2 |
0.699 | -0.034 | -2 | 0.625 |
PKCE |
0.699 | 0.106 | 2 | 0.522 |
CDK4 |
0.698 | 0.013 | 1 | 0.539 |
GRK2 |
0.698 | 0.005 | -2 | 0.514 |
MARK4 |
0.698 | -0.028 | 4 | 0.677 |
CAMK1D |
0.698 | 0.069 | -3 | 0.571 |
RSK3 |
0.698 | 0.125 | -3 | 0.668 |
CDK1 |
0.697 | 0.029 | 1 | 0.580 |
MLK3 |
0.697 | -0.047 | 2 | 0.551 |
PAK3 |
0.697 | 0.131 | -2 | 0.811 |
IRAK4 |
0.697 | -0.134 | 1 | 0.635 |
DYRK1B |
0.697 | 0.052 | 1 | 0.554 |
IRE2 |
0.697 | -0.029 | 2 | 0.552 |
PDHK1 |
0.697 | -0.219 | 1 | 0.766 |
PKCH |
0.696 | 0.035 | 2 | 0.519 |
AMPKA2 |
0.696 | 0.004 | -3 | 0.665 |
DSTYK |
0.696 | -0.072 | 2 | 0.677 |
AKT3 |
0.696 | 0.175 | -3 | 0.559 |
MLK4 |
0.696 | -0.067 | 2 | 0.539 |
PLK2 |
0.696 | 0.108 | -3 | 0.803 |
CHAK1 |
0.696 | -0.087 | 2 | 0.542 |
CHK2 |
0.696 | 0.050 | -3 | 0.563 |
CDK6 |
0.695 | 0.012 | 1 | 0.548 |
DYRK4 |
0.695 | 0.086 | 1 | 0.527 |
ERK2 |
0.695 | -0.041 | 1 | 0.566 |
HIPK4 |
0.695 | 0.045 | 1 | 0.643 |
SSTK |
0.695 | 0.032 | 4 | 0.621 |
P70S6K |
0.695 | 0.082 | -3 | 0.613 |
MNK2 |
0.694 | 0.146 | -2 | 0.830 |
NDR2 |
0.694 | 0.108 | -3 | 0.674 |
PKCG |
0.694 | 0.052 | 2 | 0.541 |
GSK3B |
0.694 | -0.017 | 4 | 0.377 |
CAMK2D |
0.694 | -0.063 | -3 | 0.676 |
PRKD3 |
0.693 | 0.053 | -3 | 0.635 |
NEK9 |
0.693 | -0.247 | 2 | 0.594 |
WNK3 |
0.693 | -0.128 | 1 | 0.709 |
PKCI |
0.693 | 0.059 | 2 | 0.533 |
CAMK2B |
0.693 | 0.018 | 2 | 0.636 |
SRPK2 |
0.693 | 0.117 | -3 | 0.611 |
PKCZ |
0.693 | -0.006 | 2 | 0.559 |
LATS2 |
0.692 | 0.047 | -5 | 0.724 |
P38G |
0.692 | -0.012 | 1 | 0.496 |
DNAPK |
0.692 | -0.055 | 1 | 0.572 |
HUNK |
0.692 | -0.080 | 2 | 0.588 |
CDK13 |
0.692 | 0.006 | 1 | 0.571 |
PRKD2 |
0.692 | 0.090 | -3 | 0.642 |
HIPK2 |
0.691 | 0.073 | 1 | 0.496 |
CAMK1G |
0.691 | 0.057 | -3 | 0.646 |
CAMK2A |
0.691 | 0.028 | 2 | 0.658 |
MELK |
0.691 | -0.030 | -3 | 0.653 |
TLK2 |
0.691 | -0.153 | 1 | 0.679 |
TBK1 |
0.691 | -0.100 | 1 | 0.674 |
CDK12 |
0.690 | 0.011 | 1 | 0.542 |
PDHK3_TYR |
0.690 | 0.135 | 4 | 0.722 |
PKCB |
0.690 | 0.012 | 2 | 0.542 |
CDK2 |
0.690 | -0.011 | 1 | 0.690 |
MAPKAPK3 |
0.690 | 0.006 | -3 | 0.630 |
SBK |
0.690 | 0.056 | -3 | 0.521 |
ERK7 |
0.690 | -0.039 | 2 | 0.393 |
QSK |
0.689 | 0.025 | 4 | 0.656 |
IRE1 |
0.689 | -0.080 | 1 | 0.633 |
PKCT |
0.689 | 0.050 | 2 | 0.529 |
GSK3A |
0.689 | -0.009 | 4 | 0.391 |
CDK16 |
0.689 | 0.003 | 1 | 0.528 |
ULK2 |
0.688 | -0.183 | 2 | 0.570 |
ERK1 |
0.688 | -0.020 | 1 | 0.524 |
IKKE |
0.688 | -0.081 | 1 | 0.676 |
CAMK1A |
0.688 | 0.079 | -3 | 0.576 |
NEK3 |
0.687 | -0.216 | 1 | 0.632 |
QIK |
0.687 | -0.058 | -3 | 0.663 |
PRKD1 |
0.687 | 0.018 | -3 | 0.680 |
NIM1 |
0.687 | -0.065 | 3 | 0.710 |
IRAK1 |
0.686 | -0.184 | -1 | 0.541 |
RIPK2 |
0.686 | -0.127 | 1 | 0.665 |
MARK3 |
0.686 | 0.011 | 4 | 0.645 |
TLK1 |
0.686 | -0.169 | -2 | 0.585 |
TESK1_TYR |
0.686 | 0.056 | 3 | 0.810 |
EPHA6 |
0.685 | 0.194 | -1 | 0.619 |
ATM |
0.685 | -0.051 | 1 | 0.660 |
P38D |
0.685 | -0.009 | 1 | 0.477 |
IKKB |
0.685 | -0.049 | -2 | 0.556 |
BMPR2_TYR |
0.685 | 0.212 | -1 | 0.676 |
PDHK4_TYR |
0.684 | 0.123 | 2 | 0.722 |
MARK1 |
0.684 | -0.024 | 4 | 0.652 |
CDK3 |
0.684 | 0.024 | 1 | 0.526 |
CDK17 |
0.684 | -0.014 | 1 | 0.510 |
MARK2 |
0.684 | -0.032 | 4 | 0.605 |
MAP2K6_TYR |
0.683 | 0.106 | -1 | 0.636 |
MAPKAPK2 |
0.683 | 0.061 | -3 | 0.617 |
NEK6 |
0.683 | -0.113 | -2 | 0.641 |
NEK7 |
0.682 | -0.199 | -3 | 0.670 |
CDK9 |
0.682 | -0.033 | 1 | 0.571 |
PINK1_TYR |
0.681 | 0.051 | 1 | 0.770 |
JNK1 |
0.681 | -0.033 | 1 | 0.570 |
CDK7 |
0.681 | -0.033 | 1 | 0.599 |
PAK6 |
0.681 | 0.164 | -2 | 0.813 |
MAP2K4_TYR |
0.680 | 0.009 | -1 | 0.624 |
MAP2K7_TYR |
0.680 | -0.016 | 2 | 0.671 |
CDK18 |
0.679 | -0.014 | 1 | 0.539 |
GCN2 |
0.679 | -0.098 | 2 | 0.594 |
PKMYT1_TYR |
0.679 | -0.048 | 3 | 0.778 |
CDK8 |
0.678 | -0.029 | 1 | 0.593 |
STK33 |
0.678 | -0.112 | 2 | 0.445 |
NUAK1 |
0.678 | -0.028 | -3 | 0.649 |
LIMK2_TYR |
0.677 | -0.014 | -3 | 0.707 |
SMG1 |
0.677 | -0.138 | 1 | 0.645 |
PDHK1_TYR |
0.677 | 0.060 | -1 | 0.647 |
SNRK |
0.676 | -0.043 | 2 | 0.540 |
TXK |
0.676 | 0.145 | 1 | 0.835 |
GRK4 |
0.676 | -0.112 | -2 | 0.583 |
EPHA4 |
0.675 | 0.106 | 2 | 0.640 |
SIK |
0.675 | -0.012 | -3 | 0.628 |
PKN1 |
0.674 | 0.032 | -3 | 0.615 |
ULK1 |
0.674 | -0.169 | -3 | 0.649 |
IKKA |
0.673 | -0.042 | -2 | 0.515 |
PHKG2 |
0.673 | 0.013 | -3 | 0.655 |
GRK3 |
0.673 | -0.006 | -2 | 0.469 |
EPHB4 |
0.673 | 0.075 | -1 | 0.558 |
PHKG1 |
0.672 | -0.063 | -3 | 0.667 |
FER |
0.672 | 0.039 | 1 | 0.852 |
INSRR |
0.672 | 0.054 | 3 | 0.700 |
YANK3 |
0.672 | -0.029 | 2 | 0.309 |
RET |
0.672 | -0.010 | 1 | 0.726 |
PLK4 |
0.672 | -0.147 | 2 | 0.473 |
TTBK2 |
0.671 | -0.207 | 2 | 0.472 |
LIMK1_TYR |
0.671 | -0.108 | 2 | 0.640 |
LCK |
0.670 | 0.135 | -1 | 0.627 |
YES1 |
0.670 | 0.048 | -1 | 0.594 |
PKG1 |
0.670 | 0.190 | -2 | 0.824 |
SRMS |
0.670 | 0.071 | 1 | 0.850 |
TYK2 |
0.670 | -0.087 | 1 | 0.723 |
TYRO3 |
0.670 | -0.064 | 3 | 0.778 |
MST1R |
0.669 | -0.039 | 3 | 0.768 |
CSF1R |
0.669 | -0.008 | 3 | 0.761 |
CDK19 |
0.669 | -0.016 | 1 | 0.553 |
FYN |
0.669 | 0.191 | -1 | 0.651 |
ROS1 |
0.668 | -0.066 | 3 | 0.741 |
PTK2 |
0.668 | 0.206 | -1 | 0.652 |
HCK |
0.668 | 0.074 | -1 | 0.608 |
PAK5 |
0.667 | 0.155 | -2 | 0.788 |
JAK3 |
0.667 | 0.023 | 1 | 0.714 |
CK1D |
0.667 | -0.021 | -3 | 0.410 |
KIT |
0.667 | 0.019 | 3 | 0.759 |
CK2A2 |
0.667 | 0.046 | 1 | 0.768 |
FGFR2 |
0.666 | 0.004 | 3 | 0.703 |
EPHB1 |
0.666 | 0.054 | 1 | 0.825 |
EPHB2 |
0.666 | 0.083 | -1 | 0.537 |
BRSK1 |
0.666 | -0.023 | -3 | 0.646 |
FLT3 |
0.666 | -0.014 | 3 | 0.779 |
BCKDK |
0.666 | -0.192 | -1 | 0.527 |
BMX |
0.666 | 0.063 | -1 | 0.539 |
JAK2 |
0.665 | -0.091 | 1 | 0.718 |
ITK |
0.665 | 0.050 | -1 | 0.571 |
DDR1 |
0.665 | -0.084 | 4 | 0.629 |
MAPKAPK5 |
0.665 | -0.046 | -3 | 0.613 |
TEK |
0.665 | -0.019 | 3 | 0.697 |
CK1A2 |
0.664 | -0.002 | -3 | 0.418 |
EPHB3 |
0.664 | 0.032 | -1 | 0.536 |
BLK |
0.664 | 0.116 | -1 | 0.621 |
TEC |
0.663 | 0.003 | -1 | 0.501 |
EPHA7 |
0.663 | 0.070 | 2 | 0.626 |
TNK1 |
0.663 | -0.054 | 3 | 0.755 |
BRSK2 |
0.663 | -0.081 | -3 | 0.649 |
PDGFRB |
0.662 | -0.083 | 3 | 0.776 |
ABL2 |
0.662 | -0.011 | -1 | 0.563 |
SYK |
0.661 | 0.194 | -1 | 0.623 |
KDR |
0.661 | -0.002 | 3 | 0.701 |
NEK10_TYR |
0.661 | -0.070 | 1 | 0.609 |
CK1E |
0.661 | -0.014 | -3 | 0.468 |
CK2A1 |
0.661 | 0.040 | 1 | 0.751 |
FRK |
0.661 | 0.080 | -1 | 0.590 |
EPHA8 |
0.660 | 0.115 | -1 | 0.578 |
EPHA5 |
0.660 | 0.080 | 2 | 0.638 |
FGR |
0.660 | -0.054 | 1 | 0.790 |
FLT1 |
0.659 | 0.047 | -1 | 0.606 |
BTK |
0.659 | -0.049 | -1 | 0.526 |
MERTK |
0.659 | -0.026 | 3 | 0.705 |
ALK |
0.659 | -0.044 | 3 | 0.699 |
FGFR3 |
0.659 | 0.013 | 3 | 0.681 |
WEE1_TYR |
0.659 | -0.024 | -1 | 0.548 |
FAM20C |
0.659 | 0.009 | 2 | 0.506 |
PDGFRA |
0.658 | -0.107 | 3 | 0.783 |
PTK2B |
0.658 | 0.012 | -1 | 0.520 |
AXL |
0.658 | -0.088 | 3 | 0.707 |
EPHA1 |
0.658 | -0.000 | 3 | 0.730 |
LTK |
0.658 | -0.051 | 3 | 0.694 |
ERBB2 |
0.658 | 0.013 | 1 | 0.795 |
PAK4 |
0.658 | 0.159 | -2 | 0.803 |
NTRK1 |
0.658 | -0.055 | -1 | 0.558 |
MET |
0.657 | 0.019 | 3 | 0.746 |
EPHA3 |
0.657 | -0.002 | 2 | 0.617 |
KIS |
0.657 | 0.038 | 1 | 0.605 |
EPHA2 |
0.657 | 0.117 | -1 | 0.552 |
FGFR1 |
0.656 | -0.090 | 3 | 0.700 |
LYN |
0.656 | 0.045 | 3 | 0.679 |
TNK2 |
0.655 | -0.111 | 3 | 0.700 |
JAK1 |
0.655 | -0.080 | 1 | 0.660 |
ABL1 |
0.655 | -0.054 | -1 | 0.552 |
TTBK1 |
0.654 | -0.172 | 2 | 0.414 |
FLT4 |
0.654 | -0.048 | 3 | 0.672 |
EGFR |
0.653 | 0.054 | 1 | 0.755 |
DDR2 |
0.653 | -0.001 | 3 | 0.670 |
MATK |
0.653 | -0.022 | -1 | 0.522 |
SRC |
0.652 | 0.061 | -1 | 0.606 |
PTK6 |
0.651 | -0.121 | -1 | 0.505 |
MUSK |
0.650 | 0.016 | 1 | 0.728 |
YANK2 |
0.649 | -0.082 | 2 | 0.312 |
INSR |
0.649 | -0.078 | 3 | 0.685 |
TNNI3K_TYR |
0.649 | -0.122 | 1 | 0.676 |
NTRK2 |
0.648 | -0.125 | 3 | 0.698 |
CSK |
0.647 | -0.027 | 2 | 0.620 |
NTRK3 |
0.647 | -0.078 | -1 | 0.527 |
ERBB4 |
0.645 | 0.103 | 1 | 0.789 |
IGF1R |
0.644 | -0.020 | 3 | 0.619 |
FGFR4 |
0.643 | -0.024 | -1 | 0.527 |
ZAP70 |
0.643 | 0.113 | -1 | 0.585 |
FES |
0.638 | -0.010 | -1 | 0.510 |
CK1G1 |
0.617 | -0.104 | -3 | 0.451 |
CK1G3 |
0.610 | -0.081 | -3 | 0.297 |
CK1G2 |
0.606 | -0.030 | -3 | 0.377 |
CK1A |
0.598 | -0.057 | -3 | 0.341 |